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Cardiovascular diseases (CVDs) are the leading cause of death, especially in the elderly. 
Dysregulation of longevity pathways, tissue homeostasis, and energy metabolism impose stress 
on cardiovascular function, significantly fostering premature cardiovascular aging. Therefore, 
understanding the molecular basis of the above regulation is crucial to improve cardiac health 
during aging. The MTOR (mechanistic target of rapamycin kinase) signaling, as a longevity 
pathway, is the master regulator of cellular homeostasis, metabolism, and longevity. MTOR 
signaling functions through two structurally and functionally distinct multiprotein complexes, 
MTORC1 and MTORC2. Unlike MTORC1, the regulation of MTORC2 is less studied. We 
identified TGFB-INHB/activin signaling as a novel upstream regulator of MTORC2 to control 
autophagy and cardiac health during aging. Using Drosophila heart as a model system, we 
showed that cardiac-specific knockdown of TGFB-INHB/activin-like protein daw maintained the 
intact cardiac autophagic flux and cardiac contractile function in aged flies. Interesting, 
MTORC2, instead of MTORC1, has been shown to require for this daw-regulated autophagy and 
cardiac function. Specifically, the reduction of MTORC2 by knocking down its subunit rictor 
abolished the increased autophagy and beneficial cardiac effects caused by daw knockdown. 
Furthermore, activation of MTORC2 alone through rictor overexpression is sufficient to promote 
autophagic flux and preserves cardiac function with aging, suggesting a positive role of 
MTORC2 in regulating autophagy and cardiac function. Lastly, either daw knockdown or rictor 
overexpression in fly hearts prolongs lifespan, suggesting that manipulating these pathways in 
the heart has systemic effects on longevity control. Thus, our studies discover the TGFB-
INHB/activin-mediated inhibition of MTORC2 as a novel mechanism for age-dependent 
decreases in autophagic activity and cardiac health. 
xiv 
MTOR pathway has also been previously shown to regulate high-fat diet (HFD)-induced 
obesity and heart dysfunction in Drosophila. Our studies suggest that MTORC2 could protect the 
heart under HFD feeding. Upon five days of HFD feeding, the heart exhibits contractile 
dysfunction and altered mitochondrial physiology, including mitochondrial fragmentation, loss 
of mitochondrial membrane potential, and mitochondrial calcium overload. We also observed 
that the activity of MTORC2 in heart is reduced upon five days of HFD feeding. In line with this 
finding, the flies with cardiac-specific MTORC2 reduction by rictor knockdown mimic HFD-
induced cardiac and mitochondrial dysfunction even on a normal diet. Conversely, cardiac-
specific activation of MTORC2 by overexpressing rictor rescued the above HFD-induced 
cardiac and mitochondrial dysfunction, suggesting that MTORC2 provides cardioprotection 
against HFD.  
Collectively, our studies identified the novel role of MTORC2 in regulating 
cardiovascular function, possibly through mediating autophagy, mitochondrial function during 





CHAPTER 1.    GENERAL INTRODUCTION 
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in the 
elderly population. By 2030, approximately 20% of the population will be aged 65 or older, and 
40% of deaths among this age group are predicted to result from CVD (Heidenreich et al., 2011). 
As the most important risk factor, aging imposes various stresses altering cardiovascular function 
and structure, thereby contributing to the development of CVD. For example, the heart 
undergoes complex phenotypic changes such as progressive myocardial remodeling, declined 
myocardial contractile capacity, increased left ventricular wall thickness and chamber size, 
prolonged diastole, and increased arrhythmia during aging (Lakatta & Levy, 2003; Strait & 
Lakatta, 2012). Moreover, the prevalence of metabolic disorder, such as obesity, diabetes, is 
significantly increased with aging, contributing to the development of the secondary diseases, 
including CVD. Recent decades, with the discovery of the beneficial effects of caloric restriction 
(CR) on healthspan in several model organisms (Harper, Leathers, & Austad, 2006; Liao, Rikke, 
Johnson, Diaz, & Nelson, 2010; Swindell, 2012), many molecular mechanisms have been 
identified regulating CR-mediated protection of the cardiovascular systems. Remarkably, the 
molecular pathways involved in tissue homeostasis and nutrient sensing, such as autophagy and 
mitochondrial metabolism, are highly interactive to regulate age-related CVD (North & Sinclair, 
2012). This general introduction section will summarize some of the essential cellular processes 
and molecular pathways implicated in the development of CVD.  
1.1 Longevity Pathways and CVD 
In the past decades, abundant studies on the relationship between diets and longevity 
have revealed many longevity genes in various model organisms that promote cellular defenses 
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against aging and age-related defenses. Many of the longevity genes or pathways are particularly 
involved in CR-mediated cardiac protection. Among them, insulin/insulin-like growth factor 1 
(IGF-1), mechanistic target of rapamycin (MTOR), AMP-activated kinase (AMPK), and 
nicotinamide adenine dinucleotide (NAD)+-dependent deacetylases sirtuins (SIRT) are the most 
important players at the central longevity regulation triggered by CR (North & Sinclair, 2012). 
This section will review two primary molecular regulators of lifespan and cardiac health, IGF-1 
and MTOR, because of their immediate relevance to our current studies. 
1.1.1 Insulin/IGF-1 Signaling 
The inactivation of the corresponding genes related to IGF-1 signaling leads to lifespan 
extension in various organisms such as nematodes (Kimura, Tissenbaum, Liu, & Ruvkun, 1997), 
fruit flies (Altintas, Park, & Lee, 2016), and mice (Junnila, List, Berryman, Murrey, & Kopchick, 
2013). IGF-1 is synthesized primarily in the liver and is acting downstream of growth hormone 
to stimulate systematic body growth and anabolic processes. The insulin/IGF-1 signaling is 
mediated by binding to its specific receptor IGF-1 receptor (IGF1R), a membrane-bound 
receptor tyrosine kinase. The binding of IGF-1 to the ⍺ subunit of IGF1R leads to the 
conformational change in the β subunit, which activates receptor tyrosine kinase activity by 
enhancing the autophosphorylation of the β subunit in numerous tyrosine residues (Hanks, 
Quinn, & Hunter, 1988). Numerous docking proteins containing the phosphotyrosine binding 
(PTB) domain or/and Src homology 2 (SH2) domain recognize the specific tyrosine 
phosphorylated sites on the β subunit and then bind to the IGF1R. Sometimes, multiple tyrosine 
sites on these docking proteins can be further phosphorylated and then serve as docking sites 
again to bring many other interacting proteins, thereby inducing a magnitude of downstream 
signaling cascades (Hakuno & Takahashi, 2018). However, phosphorylation of other tyrosine 
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residues on the β subunit of IGF1R may lead to different outcomes such as ubiquitination and 
degradation of the IGF1R, resulting in possible feedback mechanisms of which the downstream 
targets negatively regulate the insulin/IGF-1 signaling pathway (Girnita, Worrall, Takahashi, 
Seregard, & Girnita, 2014). Two major signaling pathways downstream of insulin/IGF-1 
signaling are PI3K-AKT and RAS-MAPK signaling, where PI3K-AKT signaling regulates most 
of the metabolic effects of insulin/IGF-1 signaling and Ras-MAPK signaling controls most of the 
mitogenic effects of insulin/IGF-1 signaling (Taniguchi, Emanuelli, & Kahn, 2006).   
PI3K-AKT signaling pathway 
IGF1R activation triggers its interaction with p85, the regulatory subunit of 
phosphoinositide 3-kinase (P13K), to activate PI3K. Activated P13K phosphorylates 
phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-triphosphate (PIP3). 
PIP3 then binds with phosphoinositide-dependent kinase 1 (PDK1) to phosphorylate threonine 
308 residue of protein kinase B (PKB, also known as AKT). The mechanistic target of 
rapamycin complex 2 (MTORC2) can also phosphorylate PKB/AKT at serine 473 residue upon 
the stimulation of growth hormone (Hakuno & Takahashi, 2018). Activated PKB/AKT 
phosphorylates several substrates, including the mechanistic target of rapamycin complex 1 
(MTORC1), glycogen synthase 3β (GSK3β), forkhead box-containing protein, O sub-family 
(FOXO1), AKT substrate of 160 kDa (AS160), tuberous sclerosis 1 (TSC1), and many more 
recently identified novel substrates. For example, activated Akt phosphorylates MTORC1, which 
promotes protein synthesis and ribosome production (Vadlakonda, Dash, Pasupuleti, Anil 
Kumar, & Reddanna, 2013). Activation of PI3K-AKT signaling triggers the inhibitory 
phosphorylation of GSK3β, the key mediator for glycogen metabolism, which also plays roles in 
development (e.g., Wnt signaling) and inflammatory response (e.g., NFkB signaling) (Frame & 
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Cohen, 2001; Lee & Kim, 2007). This P13K-AKT pathway also leads to inactivation of FOXO1, 
preventing FOXO-mediated expression of negative cell-cycle regulators and pro-apoptotic genes 
(X. Zhang, Tang, Hadden, & Rishi, 2011). Altogether, phosphorylating various AKT substrates 
results in the regulation of various IGF bioactivities, particularly promoting cell growth and 
maturation.  
Ras-MAPK pathway 
The interaction between IGFR1 and the growth factor receptor-bound protein 2 (GRB2) 
leads to the recruitment of Ras-guanine nucleotide exchange factor Son of Sevenless (SOS), 
which results in the activation of Ras small GTPase. Activated Ras triggers the activation of the 
mitogen-activated protein kinase (MAPK) pathway cascade, which in turn phosphorylates its 
downstream transcriptional activators, particularly those required for the DNA synthesis and cell 
survival (Hakuno & Takahashi, 2018; Wrigley, Arafa, & Tropea, 2017).  
1.1.2 MTOR Signaling 
MTOR is a serine/threonine protein kinase of PI3K-related kinase (PIKK) family that 
forms the catalytic subunit of two functionally and structurally distinct protein complexes, 
known as MTORC1 and MTORC2. MTORC1 consists of three core components, MTOR, 
RAPTOR (regulatory protein associated with MTOR), and MLST8 (mammalian lethal with 
sec13 protein 8, also known as GβL). RAPTOR interacts with MTOR HEAT repeats to facilitate 
substrate recruitment and subcellular localization of MTORC1 (Foster et al., 2010; Nojima et al., 
2003). MLST8 is associated with the kinase domain of MTOR possibly to stabilize the kinase 
activation loop (H. Yang et al., 2013). MTORC1 also contains two inhibitory subunits PRAS40 
(proline-rich AKT substrate of 40kDa), which directly inhibits substrate binding to MTOR (L. 
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Wang, Harris, Roth, & Lawrence, 2007); and DEPTOR (DEP domain containing MTOR 
interacting protein), which inhibits MTOR kinase activity (Catena & Fanciulli, 2017). MTORC2 
contains MTOR, MLST8, and DEPTOR as well. However, MTORC2 contains RICTOR 
(rapamycin insensitive comparison of MTOR) instead of RAPTOR even though it plays an 
analogous role as RAPTOR. In addition, MTORC2 contains the regulatory subunits SIN1 
(stress-activated protein kinase-interaction protein 1), which possibly regulates MTORC2 
complex integrity and kinase activity (Q. Yang, Inoki, Ikenoue, & Guan, 2006); and 
PROTOR1/2 (protein observed with RICTOR), which has been proposed to play a role in 
phosphorylating MTORC2 substrates SGK1 (serum/glucocorticoid regulated kinase 1) (Pearce, 
Sommer, Sakamoto, Wullschleger, & Alessi, 2011).  
MTOR is a master regulator of cellular growth and metabolism in response to nutrient 
and hormonal changes and a well-known longevity factor for a long time. As its full name 
indicated, rapamycin is a selective inhibitor of MTOR. Rapamycin binds with the FK506-
binding protein FKBP12 to form a complex, which in turn interacts with the FKBP12-
Rapamycin binding (FRB) domain on MTOR and inhibits MTORC1 activity via blocking 
substrate recruitment and impeding active site access (H. Yang et al., 2013). Many studies have 
shown that rapamycin extends lifespan in yeast (Powers  3rd, Kaeberlein, Caldwell, Kennedy, & 
Fields, 2006), nematodes (Robida-Stubbs et al., 2012), fruit flies (Bjedov et al., 2010) and mice 
(Harrison et al., 2009). However, MTORC2 is insensitive to acute rapamycin treatment because 
the rapamycin-FKBP12 complex does not directly bind to or inhibit MTORC2 even though 
prolonged rapamycin treatment can still abrogate MTORC2 activity, likely due to that the 




The downstream targets and upstream regulators of MTORC1 
MTORC1 signaling plays a central role in regulating cell growth in response to 
environmental conditions through promoting proteins, lipids synthesis, and suppressing the 
catabolic processes such as autophagy. Specifically, MTORC1 signaling promotes protein 
synthesis mainly through regulating mRNA translation by phosphorylating its downstream 
substrates p70S6 Kinase 1 (S6K1) and eIF4E Binding Protein (4EBP). MTORC1 directly 
phosphorylates and activates S6K1 at Thr389, which in turn phosphorylates several substrates, 
including the translation initiation factor eIF4B, eIF4B inhibitor PDCD4, and the elongation 
factor 2 kinase (eEF2K) to influence mRNA translation (Arif, Jia, Willard, Li, & Fox, 2019; 
Dorrello et al., 2006; Holz, Ballif, Gygi, & Blenis, 2005; Xuemin Wang et al., 2014). Another 
MTORC1 substrate, 4EBP, which is unrelated to S6K1, also inhibits translation by binding to 
and sequestering the translation initiation factor eIF4E from forming a complex with eIF4F. 
However, phosphorylating 4EBP by MTORC1 could also leads to 4EBP dissociation from 
eIF4E, which in turn enables the mRNA translation (Brunn et al., 1997; Gingras et al., 1999).  
MTORC1 signaling promotes de novo lipid synthesis through sterol regulatory-element 
binding protein (SREBP), which is the transcriptional factor that controls the gene expression of 
lipid synthesis and cholesterol regulation (Shimano & Sato, 2017). MTORC1 signaling activates 
SREBP directly or through S6K1 phosphorylation (Düvel et al., 2010; Porstmann et al., 2008). 
MTORC1 could also phosphorylate and prevent Lipin1, a SREBP inhibitor, to promote lipid 
synthesis (Peterson et al., 2011).  
MTORC1 regulates glucose metabolism by enhancing glycolysis mainly through 
hypoxia-inducible factor 1 (HIF1), a transcriptional factor regulating multiple cellular adaptive 
responses (Nagao, Kobayashi, Koyasu, Chow, & Harada, 2019). MTORC1 has shown to 
enhance the activity of HIF1⍺, which in turn promotes the expression of multiple glycolytic 
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enzymes (Land & Tee, 2007). Additionally, the MTORC1-dependent activation of SREBPs 
mentioned above increases flux through the oxidative pentose phosphate pathway (PPP) so that 
more glucose is utilized to generate NADPH and other metabolic intermediates needed for 
growth (Saxton & Sabatini, 2017).  
To maintain the delicate equilibrium between synthesizing and degrading protein, 
MTORC1 also controls processes involved in protein homeostasis, such as autophagy and the 
ubiquitin-proteasome system (UPS). Autophagy is the regulated mechanism that removes or 
recycles damaged proteins and organelles. Further detail of autophagy is reviewed in a later 
section. Influenced by cellular nutrient and growth factor levels, activated MTORC1 
phosphorylates multiple autophagy-related genes such as ULK1, ATG13, and ATG14L to inhibit 
autophagy initiation and autophagosome nucleation. MTORC1 also negatively regulates 
autophagy via phosphorylating and inhibiting the nuclear localization of the transcriptional factor 
TFEB, which regulates the gene expression for lysosomal biogenesis and other autophagy 
machinery (Y. C. Kim & Guan, 2015). UPS is another major process to maintain protein 
homeostasis, through which the ubiquitin molecules target proteins for degradation. Previous 
evidence suggests that acute MTORC1 inhibition by rapamycin or Torin1 rapidly increases 
proteolysis by proteasomes in addition to autophagy (J. Zhao, Zhai, Gygi, & Goldberg, 2015). 
Interestingly, elevated proteasome activity is also observed under the hyperactivation of 
MTORC1 signaling (Y. Zhang et al., 2014). One possible explanation for these contradictory 
results is that acute MTORC1 inhibition promotes proteolysis to restore amino acid pools, while 
prolonged MTORC1 activation increases proteolysis to compensate for the increased global 
protein synthesis (H. Yang et al., 2013).  
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As mentioned above, MTORC1 signaling activates several signaling cascades in response 
to the environmental cues. To date, several inputs are known to regulate MTOR activity. To 
summarize, MTORC1 responds to cellular growth factors, nutrient levels, and stressed 
conditions, such as starvation, hypoxia, or DNA damage.  
MTORC1 is a downstream mediator for several growth hormones, and the MTORC1 
negative regulator TSC is thought to be the major player in response to these growth hormones. 
TSC serves as a GTPase activating protein (GAP) to hydrolyze and inhibit RHEB, which is a 
small GTP-binding protein activating MTOR. RHEB localizes with MTORC1 primarily on the 
lysosomal membrane to activate MTORC1 activity even though the detailed mechanism of 
RHEB-dependent MTORC1 activation is unclear (Inoki, Li, Xu, & Guan, 2003). Upon insulin or 
growth factor stimulation, several kinases, including PKB/AKT, phosphorylates and inhibits 
TSC by dissociating it from the lysosomal membrane, which in turn suppresses the GAP activity 
of TSC and prevents it from interacting and hydrolyzing RHEB, thereby activating MTOR to 
stimulate GTP hydrolysis and protein synthesis (Astrinidis & Henske, 2005; Inoki, Li, Zhu, Wu, 
& Guan, 2002). Other signaling pathways, such as MAPK signaling, are also reported to inhibit 
TSC activity in response to growth factors (Ma, Chen, Erdjument-Bromage, Tempst, & Pandolfi, 
2005).   
MTORC1 signaling controls multiple metabolism pathways by sensing nutrient levels, 
especially for amino acids. MTORC1 is located on the lysosomal membrane to sense both intra-
lysosomal and cytosolic amino acids through Rag GTPases. The lysosomal and cytosolic amino 
acids activate Rags, allowing them to bind with RAPTOR and recruit MTORC1 to the lysosomal 
membrane (T. P. Nguyen, Frank, & Jewell, 2017).  Specifically, the lysosomal amino acid 
transporter SLC38A9 (solute carrier family 38 member 9) interacts with Rags to sense intra-
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lysosomal arginine levels (Jung, Genau, & Behrends, 2015). Sestrin2, a cytosolic leucine sensor, 
and CASTOR1, a cytosolic arginine sensor, interacts with GATOR1/2 to inhibit MTORC1 via 
Rags under amino acid deprivation (Chantranupong et al., 2016, 2014)  
MTORC1 also responds to energy stresses that are incompatible with growth, such as 
nutrient deprivation, DNA damage, and hypoxia. 5' adenosine monophosphate-activated protein 
kinase (AMPK) is the major MTORC1 upstream regulator involved in stress response. For 
example, under glucose deprivation conditions, AMPK inhibits MTORC1 both directly through 
phosphorylating RAPTOR or indirectly through phosphorylating and activating TSC (Gwinn et 
al., 2008; Inoki, Zhu, & Guan, 2003). Hypoxia and DNA damage also inhibit MTORC1 partly 
through AMPK activation (Brugarolas et al., 2004; Z. Feng et al., 2007). However, MTORC1 
activity is still inhibited even without AMPK under certain stress conditions, suggesting that 
MTORC1 utilizes multiple other mechanisms to cope with various stress conditions (Kalender et 
al., 2010).  
The downstream targets and upstream regulators of MTORC2 
Unlike MTORC1, MTORC2 signaling is less characterized. However, increasing 
evidence suggests that MTORC2 involves cellular proliferation, architecture, and survival. 
Proteins in AGC (PKA/PKG/PKC) protein kinase family, including AKT, SGK1, and several 
members of PKC family are the best-characterized substrates of MTORC2 (H. Yang et al., 
2013). AKT is phosphorylated at Ser473 by MTORC2, which enhances insulin/PI3K signaling 
activities or its related pathways to promote cell survival, proliferation, and growth (Sarbassov, 
Guertin, Ali, & Sabatini, 2005). Ser473 phosphorylation of AKT can also induce the 
phosphorylation of the MTORC1 inhibitor TSC2, which impairs the ability of TSC2 to inhibit 
MTORC1, even though the MTORC2-dependent phosphorylation is not required for AKT to 
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phosphorylate TSC2 (Huang & Manning, 2009). MTORC2 also phosphorylates SGK1 to affect 
ion transport, and SGK1 has been suggested to play roles in promoting cardiomyocyte survival 
and inhibiting hypertrophy (Takuma et al., 2005; H. Yang et al., 2013). Finally, MTORC2 
phosphorylates several members of the PKC family, including PKC⍺, PKCδ, PKCγ, PKCε, and 
PKC𝜁 to regulate cytoskeleton remodeling and cell migration (Gan et al., 2012; Jacinto et al., 
2004; X. Li & Gao, 2014; Thomanetz et al., 2013). 
As an effector in insulin/PI3K signaling, MTORC2 responds to growth factors. The 
MTOR2 subunit SIN1 inhibits MTORC2 activity in the absence of insulin (P. Liu et al., 2015). 
However, MTORC2 seems to be less sensitive to nutrient deprivation than MTORC1 (Kapahi et 
al., 2010). SIN1 can also be phosphorylated by AKT, which might represent a positive feedback 
loop regulation, where partially activated AKT could enhance its own activation by further 
promoting MTORC2-dependent AKT phosphorylation (G. Yang, Murashige, Humphrey, & 
James, 2015). Interestingly, MTORC2 signaling is also negatively regulated by MTORC1 due to 
the negative feedback loop, where MTORC1 inhibits the insulin/PI3K pathway via 
phosphorylating and activating GRB10, a negative regulator of insulin/IGF-1 signaling (Hsu et 
al., 2011). MTORC1 signaling substrate S6K1 can also inhibit MTORC2 activity via 
phosphorylating and promoting degradation of MTORC2 signaling upstream effector insulin 
receptor substrate 1 (IRS1) (Harrington et al., 2004).  
So far, the functioning location for MTORC2 is less clear. Previous evidence suggests 
that MTORC2 interacts with the endoplasmic reticulum (ER) proteins (Martin, Masri, Bernath, 
Nishimura, & Gera, 2008; Ramírez-Rangel et al., 2011) and is sensitive to ER stress 
(Appenzeller-Herzog & Hall, 2012; C.-H. Chen et al., 2011; Hosoi, Hyoda, Okuma, Nomura, & 
Ozawa, 2007). Other studies showed that mitochondrial membrane potential, respiration, and the 
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phosphorylation of several mitochondrial proteins are altered after rapamycin treatment or Rictor 
knockdown in Jurkat cells (Desai, Myers, & Schreiber, 2002; Schieke et al., 2006). It has been 
known that long-term rapamycin treatment can also affect MTORC2 function (Sarbassov et al., 
2006). A recent study investigating the localization of MTORC2 showed that it localizes to the 
mitochondrial-associated ER membrane (MAM) even though it is not fully understood how and 
in what chronological order MTORC2 signaling occurs (Betz, Stracka, Prescianotto-baschong, 
Frieden, & Demaurex, 2013). MAM links mitochondria and ER membrane by regulating several 
essential functions, including calcium exchange, lipid transfer, and mitochondrial dynamics 
(Lopez-Crisosto et al., 2017). MAM is also a signaling hub to sense nutrient level changes and 
ER stress (Theurey & Rieusset, 2017). Interestingly, MTORC2 is also involved in many of these 
MAM-related regulations, suggesting that MTORC2 might be an important player in MAM 
signaling hub.  
MTOR and CVD 
As mentioned earlier, MTOR signaling has long been considered a key factor regulating 
aging. MTOR inhibitor rapamycin has been proven to extend lifespan in various model 
organisms. There are nine hallmarks of aging, including genomic instability, telomere attrition, 
epigenetic alteration, loss of proteostasis, deregulated nutrient sensing, mitochondrial 
dysfunction, cellular senescence, and altered intercellular communication (López-Otín, Blasco, 
Partridge, Serrano, & Kroemer, 2013). The role of MTOR in many of the above processes has 
been reviewed previously, suggesting MTOR is a central regulator of aging. MTOR signaling is 
also essential for many aspects of the cardiovascular system, such as regulating cardiovascular 
development, homeostasis, and adaptation to stress (Sebastiano, Maurizio, Giacomo, & Junichi, 
2018). MTOR regulates cardiovascular development both during the embryonic stage and 
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postnatal life. Mice with deletion or disruption of Mtor or Raptor genes showed high embryonic 
lethality and early mortality in the postnatal stage, along with massive cardiac dilatation, heart 
failure, autophagy, mitochondrial and metabolic abnormalities (Sciarretta, Volpe, & Sadoshima, 
2014). However, activating MTORC1 is also responsible for many maladaptive effects under 
chronic stress, including the development of pathological cardiac hypertrophy, misfolded protein 
accumulation, and increased energy stress. Thus, despite the important role of MTOR in cardiac 
development, partial inhibition of MTORC1 activity is beneficial for maintaining cardiac 
function in response to pressure overload, ischemic injury, metabolic dysfunction, and aging.  
MTORC1 also plays roles in response to hypertrophic signals such as pressure overload. 
Deregulated MTORC1 activation in heart results in the development of pathological cardiac 
hypertrophy even though MTORC1 overexpression alone is not sufficient to induce hypertrophy, 
suggesting that MTORC1 interacts with other signaling pathways together to respond to 
hypertrophic stimuli (Shen et al., 2008). On the other hand, reduced MTORC1 activity by 
rapamycin treatment or Tsc1 overexpression has shown to reduce hypertrophy and improve 
cardiac function, suggesting that partial inhibition of MTORC1 can be beneficial in hypertrophic 
conditions as well (R. et al., 2004; H.-M. Zhang, Diaz, Walsh, & Zhang, 2017). MTORC1 also 
has been shown to regulate cardiac response to ischemia, where MTORC1 activity is inhibited to 
promote cell survival mechanisms, including autophagy, energy preservation, and degrading 
misfolded protein (Sciarretta et al., 2012). Reactivation of MTORC1 by Rheb overexpression or 
attenuation of ischemia-induced MTORC1 inhibition by reducing GSK-3β activity inhibits 
autophagy and promotes cell death, thereby increasing ischemic injury (Sciarretta et al., 2012; 
Zhai, Sciarretta, Galeotti, Volpe, & Sadoshima, 2011). Cardiac activation of MTORC1 also 
contributes to cardiac dysfunction resulted from metabolic disorders. For example, MTOR 
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activation in obese mice impairs autophagosome formation, thus affects cardiac function (Guo, 
Zhang, Turdi, & Ren, 2013). Similarly, the cardiac dysfunction, including reduced cardiac 
contractility and pathological morphology change, resulted from high-fat diet (HFD) feeding 
were efficiently alleviated by inhibiting insulin-MTOR signaling via Tsc1/2 or Thor knockdown 
(Ryan T Birse et al., 2010).  
MTORC2, on the other hand, is essential for the later stage of embryonic development 
with respect to MTORC1. Mice with the global deletion of Rictor also showed high embryonic 
lethality even though Rictor-/- embryos die significantly later than Raptor-/- ones (Guertin et al., 
2006). Even though cardiac deletion of rictor in adulthood does not significantly affect basal 
cardiac function, MTORC2 disruption impairs the ability of heart to adapt to stress (Chang et al., 
2019; Shende et al., 2016). Moreover, activating MTORC2 upregulates autophagy activity in 
heart with aging, thus alleviates age-induced cardiac dysfunction (Chang et al., 2019). 
Interestingly, MTORC2 positively regulates autophagy, which is the opposite of autophagy 
regulation by MTORC1, suggesting autophagy is regulated by MTOR through a more 
complicated mechanism, possibly involving a feedback regulation.  
In summary, MTOR complexes exert both adaptive and maladaptive functions. The 
mechanisms underlying these dual functions await to be examined on a deeper level.  
1.2 Autophagy and CVD 
Autophagy is a highly conserved process that maintains tissue and cellular homeostasis. 
Microautophagy, chaperon-mediated autophagy, and macroautophagy are three identified 
pathways of autophagy. Macroautophagy (simply referred to as autophagy hereafter) is the 
pathway that will be the focus of our study. The autophagic process initiates with the isolated 
membrane or phagophore that elongates to form a double-membrane structure known as the 
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autophagosome. Then the autophagosome fuses with a lysosome to form an autolysosome to 
degrade the enclosed materials along with the autophagosomal membrane (Shibutani & 
Yoshimori, 2014). On one hand, autophagy maintains cellular energy production by sensing the 
nutrient level and functions non-selectively to degrade a wide range of intracellular components 
targeted for nutrients recycling. On the other hand, autophagy also functions selectively on 
damaged organelles, thus affecting cellular survival. For example, mitophagy is responsible for 
the clearance of damaged mitochondria (Sica et al., 2015). Besides, autophagy not only preserves 
organismal homeostasis under the basal conditions but also contributes to cellular adaptation to 
various stress conditions such as starvation, hypoxia, oxidative stress, and exercise (He et al., 
2012; Kroemer, Mariño, & Levine, 2010). In Drosophila, the components of autophagy can be 
divided into several function units, and they are: (1) the serine/threonine protein kinase complex 
Atg1 (ULK1, ULK2 in mammals), commonly considered as the initiator of the autophagy 
machinery; (2) two ubiquitin-like conjugation systems, Atg12 (covalently conjugated to Atg5), 
and Atg8 [(LC3 in mammals) conjugated to the lipid molecule phosphatidylethanolamine (PE)]; 
and (3) a protein complex containing the class III phosphatidylinositol 3-kinase, Vps34 (PI3KC3 
in mammals), that is required for autophagosome formation (Neufeld, 2012; Wong, Puente, 
Ganley, & Jiang, 2013). Evidence supports that basal autophagy plays an essential role in 
maintaining normal heart homeostasis and morphology. Disruption of autophagy by Atg5 
knockout in mouse heart has shown premature phenotype, such as increased left ventricular 
hypertrophy and decreased fractional shortening (Taneike et al., 2010). Thus, manipulation of 
autophagy machinery could potentially help to develop the therapeutic approaches to treat 
cardiovascular diseases. This section reviews some of the current understandings on the role of 
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autophagy in regulating cardiovascular function during aging and the mechanisms of this age-
related autophagy regulation.  
1.2.1 Autophagy and age-related CVD 
Autophagy plays a vital role in cell survival and longevity, particularly for permanently 
differentiated cells, such as cardiomyocytes. Cardiomyocytes require autophagy to remove or 
recycle damaged and long-lived cellular components in order to maintain homeostasis. It is 
widely accepted that autophagic activity is reduced during aging for most tissues, including heart 
(Cuervo, 2008; Del Roso et al., 2003; Nair & Ren, 2012; Rubinsztein, Mariño, & Kroemer, 
2011). Disrupting autophagy early in life results in premature heart failure and accelerating 
cardiac aging. For example, cardiomyocyte-specific Atg5 ablation leads to a significant 
acceleration in heart decline, including hypertrophy, fibrosis, impaired contractile function, 
altered cardiomyocyte morphology, mitochondrial dysfunction, enhanced oxidative stress, and 
ultimately shortened lifespan in mice (Taneike et al., 2010). In line with this finding, inhibition 
of mitophagy in mice by Parkin-knockout also accelerates the decline of overall cardiac function, 
along with increased mitochondrial DNA mutation in heart and shortened lifespan (Hoshino et 
al., 2013).  
Because of the inverse relationship between autophagy and cardiac aging, it is reasonable 
to postulate that the cardiac intervention involving autophagy activation might promote 
cardioprotective effect during aging. Indeed, extensive evidence suggests that activating 
autophagy through changing lifestyle (e.g., exercise), dietary, or applying genetic or 
pharmacological interventions attenuates age-related heart function decline (Mahmoud, Simon, 
Didac, Frank, & Guido, 2018). For instance, Akt2 ablation prolongs lifespan and attenuates 
aging-induced unfavorable changes in cardiomyocytes by restoring FOXO-related autophagy 
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mitophagy in mice (Ren et al., 2017). Collectively, these findings suggest a causal relationship 
between autophagy and cardiac aging.  
1.2.2 Autophagy and Longevity Pathways 
Autophagy is at the intersection among many longevity pathways discovered involving in 
nutrient sensing or CR and plays a positive role in lifespan extension across species. For 
example, autophagy has been proven required for CR-mediated lifespan extension in 
Caenorhabditis. elegans (Jia & Levine, 2007), and reducing insulin-like signaling by daf-2 
mutant fails to extend lifespan when the autophagy-related gene Beclin1 is inhibited (Meléndez 
et al., 2003). Moreover, CR fails to promote longevity in C. elegans when intestine-specific 
autophagy is inhibited, suggesting that some tissues may play more important roles in autophagy 
during aging (Gelino et al., 2016). In line with these findings, autophagy inhibition by reducing 
Atg5 expression also abrogates lifespan extension in Drosophila by rapamycin treatment or 
AMPK activation. Thus, it is likely that these longevity pathways regulate the reduced autophagy 
activity observed in aged organelles. 
Nutrient-sensing and longevity pathways, including MTOR, AMPK, and sirtuin1 
signaling, have been studied extensively in autophagy. For example, sirtuin1 induces autophagy 
via deacetylating Atg5, 7, and 8. It can also deacetylate FOXOs to modulate the expression of 
autophagy regulatory genes (I. H. Lee et al., 2008). MTORC1 is a well-known negative regulator 
for autophagy as well (Rabanal-Ruiz, Otten, & Korolchuk, 2017). Hyperactivation of MTOR and 
reduced AMPK activity observed in various aged organisms can inhibit autophagy initiation via 
inactivating Atg1/ULK1 complex (Hua et al., 2011; J. Kim, Kundu, Viollet, & Guan, 2011). 
MTOR also transcriptionally suppresses the expression of autophagic-related genes by 
inactivating TFEB family (Roczniak-Ferguson et al., 2012) and the FOXO family (Hariharan et 
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al., 2010). Interestingly, even though the role of MTORC2 in autophagy is unclear, our study in 
Drosophila suggested that MTORC2 might have the opposite function on autophagy with respect 
to MTORC1, where MTORC2/rictor acts downstream of TGFB-INHB/activin signaling as a 
positive autophagy regulator to slow cardiac aging (Chang et al., 2019). 
1.2.3 Other Mechanisms underlying Reduced Autophagy in Aging 
Reactive oxygen species (ROS) is thought to be a toxic factor that results in cellular 
dysfunction and aging for a long time. In recent years, increasing evidence suggests that ROS is 
predominantly beneficial to cells. Under normal physiological conditions, ROS serves as a signal 
to moderate various signaling pathways, such as autophagy. For example, moderate ROS levels 
activate autophagic activity via multiple signaling pathways such as AMPK-MTORC1-ULK1 
and KEAP1-NRF2-p62. ROS also has some impact on selective autophagy, including mitophagy 
and pexophagy (Dai, Chiao, Marcinek, Szeto, & Rabinovitch, 2014; Kaushal, Chandrashekar, & 
Juncos, 2019). However, prolonged ROS accumulation and damaged mitochondria also 
contribute to general autophagy and mitophagy reduction during aging, further contributing to 
ROS accumulation (Dai, Chiao, et al., 2014; Rubinsztein et al., 2011). Evidence showed that 
excessive ROS promotes the accumulation and aggregation of oxidized proteins, which can 
disrupt several mitochondrial dynamic proteins that are essential for mitophagy, including 
MFN1, DRP1 and FIS1 (Ikeda et al., 2014). In addition, long-term exposure in high ROS levels 
also increases mitochondrial DNA mutation, which might lead to abnormalities in other 
mitochondrial proteins that are fundamental for maintaining homeostasis during aging.  
In recent years, it has become evident that intracellular calcium (Ca2+) is a crucial 
regulator of both basal and induced autophagy machinery, especially in cardiomyocytes (Shaikh 
et al., 2016). On the one hand, Ca2+ triggers autophagy initiation by promoting the formation of 
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the initiation complex and nucleation of the phagophores (Grotemeier et al., 2010). On the other 
hand, intracellular Ca2+ also inhibits autophagosome formation and autophagosome-lysosome 
fusion (Park et al., 2014; H.-G. Xia et al., 2010). Moreover, the role of lysosomal Ca2+ has been 
studied recently in the regulation of autophagy as well. Under starvation conditions, lysosomal 
Ca2+ is increased to activate the phosphatase calcineurin, which promotes the transcription of 
autophagy-related genes by dephosphorylating and activating TFEB (Medina et al., 2015).  
In addition to mediating proteins involved in different autophagy steps, intracellular Ca2+ 
also plays a regulatory role in multiple pathways essential for autophagy initiation. For example, 
previous studies showed that increased free cytosolic Ca2+ induces autophagy, where 
Ca2+/calmodulin-dependent kinase kinase-β (CaMKKβ) activates autophagy via the AMPK-
MTOR pathway (Høyer-Hansen et al., 2007). Another MTOR-independent cellular pathway that 
involves Ca2+ and regulates autophagy is the constitutive inositol 1,4,5 triphosphate receptor 
(IP3R)-Ca2+ signaling pathway. IP3R binds to the calcium channel on ER and allows the release 
of Ca2+, which is then taken by mitochondria to support oxidative phosphorylation. Reduced 
ATP production by inhibited mitochondrial Ca2+ uptake represents a bioenergetic deficient 
condition, which activates AMPK and induces autophagy activity to adapt to stress. Conversely, 
increased IP3R-mediated calcium transfer to mitochondria inhibits autophagy via suppressing 
AMPK activation (Cárdenas et al., 2010). Interestingly, the cardiac expression level of IP3R is 
increased in aged or dysfunctional heart, suggesting that reduced autophagy activity observed 
during is possibly due to increased IP3R- Ca2+ signaling (Go et al., 1995; Gorza, Vettore, 
Tessaro, Sorrentino, & Vitadello, 1997; X. Wu et al., 2006; Yamda et al., 2001). 
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1.3 Mitochondria and CVD 
Over past years, extensive evidence suggests that mitochondrial dysfunction is one of the 
causal factors to aging and many age-related diseases. Cardiomyocytes require a constant supply 
of energy to support its contractile function. Therefore, mitochondria, as the cellular powerhouse, 
are particularly crucial for the heart. Even though the primary energy source in adult hearts is 
obtained by oxidation of fatty acids, several other organic substrates can be utilized in energy 
production as well (Stanley, Recchia, & Lopaschuk, 2005). To optimize energy utilization and 
production, mitochondria form large networks and continuously undergo mitochondrial fusion 
and fission in response to various stress and environmental cues, such as oxidative stress, 
nutrient availability, and regulating cellular survival and apoptosis (Siasos et al., 2018; 
Westermann, 2012). Extensive evidence suggests that cardiac-specific impairment of 
mitochondrial dynamic processes by disrupting the mitochondrial fusion/fission proteins is 
detrimental to cardiac health, possibly through the accumulation of non-functional mitochondria 
and excessive ROS (Nan et al., 2017; Parra et al., 2011). Therefore, the mitochondrial quality 
control process, like mitophagy, is essential to maintain the healthy pool of mitochondria by 
degrading damaged mitochondria. Indeed, as discussed in the previous section, mitophagy is a 
key determinant for cardiac health and lifespan. Moreover, mitochondria not only form networks 
with themselves, but they also intensively interact with other organelles such as ER at 
mitochondrial-ER contact sites to regulate a wide range of cellular functions, including calcium 
transfer, mitochondrial dynamics, metabolism, and autophagy (Rieusset, 2018). Therefore, 
impaired interaction between mitochondrial and ER contributes to cardiac aging and diseases (J. 
Li, Zhang, Brundel, & Wiersma, 2019). This section will review some key mitochondrial 
functions and their contribution to CVD during aging.  
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1.3.1 Mitochondrial Energetics  
The primary function of mitochondria is to produce ATP through oxidative 
phosphorylation. It is not surprising that cardiac aging is associated with mitochondrial 
bioenergetic dysfunction (Bratic & Larsson, 2013; Tatarková et al., 2011). It has been 
documented that the activities of electron transport chain (ETC) complexes, especially for 
complex I and IV (Lenaz et al., 1997; Tatarková et al., 2011), decline with age in various tissues, 
including heart (Ojaimi, Masters, Opeskin, McKelvie, & Byrne, 1999; Short et al., 2005; 
Tatarková et al., 2011). This non-uniform decline in ETC complexes activities is likely due to 
and could further induce mitochondrial oxidative damage (Tatarková et al., 2011). In addition, as 
the heart has continuously high energy requirements that mostly rely on fatty acid oxidation, the 
effect of energetic and metabolic changes may be more apparent in heart than in other organs 
during aging (Ryan Tyge Birse & Bodmer, 2011). Indeed, a previous proteomics and pathway 
analysis in heart revealed that the abundance of proteins involved in ETC, tricarboxylic acid 
(TCA) cycles, and fatty acid metabolism declines while the abundance of proteins involved in 
glycolysis and oxidative stress response increases with age. Moreover, restoring a greater 
dependence on fatty acid oxidation after CR or rapamycin treatment rescues the age-dependent 
cardiac and mitochondrial dysfunction (Dai, Karunadharma, et al., 2014), suggesting that 
targeting metabolic modulation, especially fatty acid metabolism in mitochondria, has developed 
as the therapeutic approach for age-related heart dysfunction.  
1.3.2 Mitochondrial ROS  
As indicated in the famous free radical theory of aging, intracellular ROS production is 
the causal factor of tissue aging. Even though various cellular components such as peroxisomes 
contribute to ROS production, mitochondria produce the most ROS via oxidative 
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phosphorylation, which led to the development of the mitochondrial free radical theory of aging. 
This theory specifies that mitochondrial ROS is the primary cause of aging (Harman, 1972). In 
line with the mitochondrial free radical theory of aging, previous research showed that 
overexpressing mitochondrial-targeted catalase (mCAT) in mice prolongs lifespan, whereas 
overexpressing peroxisomal or nuclear-localized catalase do not (Schriner et al., 2005). 
However, with the beneficial roles of ROS and ROS signaling have been recognized in recent 
years (Ristow, 2014), many studies manipulating antioxidant fails to support the idea that ROS is 
the causal factor for aging. For example, overexpressing the mitochondrial manganese 
superoxide dismutase 2 (SOD2) fails to prolong the lifespan in mice (Jang et al., 2009). Most 
relevant to this review, cardiac Mcat overexpression in mice protects against an age-dependent 
alteration in heart structure and decline in contractile function (Dai et al., 2009), suggesting that 
mitochondrial oxidative stress at least partly mediates cardiac aging.  
Increased mitochondrial ROS production has been reported in multiple cardiac models 
during aging (Barja, 1998; Kwong & Sohal, 1998). The generation of mitochondrial ROS mainly 
occurs at Complex I, II, III of ETC during oxidative phosphorylation. The major source of ROS 
in intact cardiomyocytes is usually from mitochondrial Complex I and III of ETC (Murphy, 
2009). Among them, Complex I is considered to be the main site of mitochondrial ROS 
production. On the one hand, ROS can be generated in the matrix during the forward electron 
transfer of NADH to Coenzyme Q (CoQ) in Complex I. On the other hand, using succinate as a 
substrate, the induction of the reverse electron transport from Complex II to Complex I also 
significantly promote ROS production at Complex I (Hirst, King, & Pryde, 2008). Under normal 
condition, the level of ROS production at the matrix by Complex II is usually negligible even 
though evidence showed that the maximum capacity of Complex II to produce ROS could be 
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very high in rat skeletal muscle based on the quantity of reduced flavoprotein (Quinlan et al., 
2012). Complex III contributes to ROS production as well, and it is a major site for net ROS 
release from mitochondria. ROS can be produced at the quinol oxidation site when electrons are 
transferred from Complex III through the Q-cycle (Turrens, Alexandre, & Lehninger, 1985). 
Altogether, ROS formed from the above processes can be released into both matrix and 
intermembrane space. The ROS at the intermembrane space can be released outside of 
mitochondria through the anion channels and ER-mitochondrial contact sites (Han, Antunes, 
Canali, Rettori, & Cadenas, 2003; Yoboue, Sitia, & Simmen, 2018). Generally speaking, there 
are two central mechanisms responsible for age-induced ROS production from cardiac 
mitochondria (Yeong-Renn & L., 2014). First, decreased respiration observed in aged tissue 
leads to flux decline through the ETC, which increases the reduction of upstream complexes, 
especially for complex I and III. Therefore the reduced redox centers are more likely to react 
directly with molecular oxygen to generate ROS (Q. Chen, Vazquez, Moghaddas, Hoppel, & 
Lesnefsky, 2003). Second, age-induced modification on ETC complexes, especially complex III, 
alters the function that favors ROS production (Moghaddas, Hoppel, & Lesnefsky, 2003).  
The increased mitochondrial ROS production initially targets the mitochondria by 
inducing more significant oxidative damage, including protein sulfhydryl oxidation, lipid 
peroxidation, and mitochondrial DNA (mtDNA) mutation (Floyd, West, & Hensley, 2001). In 
response to oxidative stress, mitochondria could also provide complementary mechanisms by 
increasing antioxidant enzyme contents. NRF2, a redox-sensitive transcription factor, is activated 
under oxidative stress to upregulate antioxidant genes and genes involved in mitochondrial 
quality control. Previous studies showed that the expression of NRF2 is decreased in the skeletal 
muscles of the elderly (Safdar, deBeer, & Tarnopolsky, 2010), wheras enhancing NRF2 
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expression may reduce the burden of cardiovascular diseases in the elderly (Silva-Palacios, 
Königsberg, & Zazueta, 2016), suggesting that lack of endogenous activation of redox-sensitive 
signaling could also contribute to ROS-induced cardiac aging.  
1.3.3 Mitochondrial Quality Control (MCQ)  
As indicated earlier, mitochondria play a crucial role in cardiac function by providing 
energy for heart contraction and involving in other functions such as metabolic signaling. 
However, cardiomyocytes are long-living cells with no dividing ability, suggesting a limited 
regenerative capacity in the heart (Hesse, Welz, & Fleischmann, 2018). Therefore, MCQ 
mechanisms, including fusion, fission, biogenesis, and mitophagy, are essential to maintain a 
healthy pool of cardiac mitochondria during aging. In response to metabolic alterations and other 
environmental cues, mitochondria continuously undergo morphological changes between fusion 
and fission. Fusion promotes mitochondrial elongation, therefore homogenizing the contents of 
damaged mitochondria; fission, on the other hand, enhances mitochondria fragmentation, which 
seems to be a prerequisite for the removal of damaged mitochondria via mitophagy. However, 
excessive or untimely fusion or fission could be detrimental to heart function as well (N. N. Wu, 
Zhang, & Ren, 2019). This section highlights key components of MCQ processes, mitochondrial 
fusion/fission and mitophagy, and their roles in cardiac aging.  
Mitochondrial fusion and fission 
The morphology of mitochondria is dependent on fusion-fission processes, which are 
mediated by dynamin-related GTPases. Mitochondrial fusion requires a coordinated fusion of the 
outer (OMM) and inner mitochondrial membrane (IMM) to join adjacent mitochondria together 
(Y. J. Liu, McIntyre, Janssens, & Houtkooper, 2020). Most of the time, OMM fusion is 
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coordinated with IMM fusion. However, OMM fusion can also occur without concomitant IMM 
fusion. For example, OMM fusion could occur alone when IMM fusion is blocked by a localized 
loss of mitochondrial membrane potential (Olichon et al., 2003). In mammals, the mitofusins 
(MFN1 and MFN2) are responsible for OMM fusion, leading to a conformational change to 
bring the opposing membranes together via GTP hydrolysis (Koshiba et al., 2004). MFN2 is also 
present at mitochondrial-ER contact sites to mediate mitochondrial constriction during the 
fission process (Basso et al., 2018; de Brito & Scorrano, 2008). Optic atrophy 1 (OPA1), on the 
other hand, is another dynamin-like GTPase localized to IMM to mediate its fusion (Y. J. Liu et 
al., 2020). There are eight different OPA1 isoforms generated by alternative splicing in 
mammals, each one of them contains a different combination of three proteolytic cleavage sites. 
Constitutive processing of OPA1 at proteolytic cleavage sites gives rise to long-OPA1 and short-
OPA1, which cooperatively modulate mitochondrial fusion. Several proteases such as OMA1 
and YME1L regulate this OPA1 cleavage in response to stress and other environmental cues 
(van der Bliek, Shen, & Kawajiri, 2013). Beyond regulating mitochondrial fusion, OPA1 might 
also play a role in maintaining cristae morphology (Griparic, van der Wel, Orozco, Peters, & van 
der Bliek, 2004). Indeed, most OPA1 proteins have been found inside cristae instead of 
localizing to the rim, where fusion is likely to occur (Frezza et al., 2006; Griparic et al., 2004). 
Abnormalities of cristae morphology could promote ROS production and other pathological 
responses (Schäfer et al., 2006). In addition to OPA1, cardiolipin, a mitochondria-specific lipid, 
is essential for IMM fusion too. The interaction between OPA1 and cardiolipin enables the 
tethering of opposing membranes and cristae formation (Ban et al., 2017).  
Mitochondrial fission starts with OMM constriction at the mitochondria-ER contact sites 
(Friedman et al., 2011a), followed by DRP1 recruitment by other adaptor proteins such as FIS1, 
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MFF, MID49, and MID51 (Losón, Song, Chen, & Chan, 2013). From there, DRP1 tubulates and 
constricts mitochondrial membranes by assembling higher-ordered spiral complexes (van der 
Bliek et al., 2013). In recent years, more and more cellular components have been identified to 
play positive roles in DRP1-mediated mitochondrial fission. For example, the role of 
mitochondrial-ER contact sites once again is highlighted in the context of mitochondrial fission. 
Previous studies showed that ER functions as the platform for DRP1 oligomerization and INF2-
mediated actin polymerization and helps the initiation and growth of ER-bound DRP1 oligomers, 
from which the DRP1 oligomers can transfer to mitochondria (Ji et al., 2017; Korobova, 
Ramabhadran, & Higgs, 2013).  
In recent years, increasing studies have revealed that fusion-fission factors are involved 
in regulating cardiac function even though the mechanisms are largely unclear. For example, 
cardiac-specific Drp1 ablation in murine leads to lethal dilated cardiomyopathy and 
cardiomyocyte necrosis. On the other hand, conditional ablating cardiomyocyte Mfn results in 
eccentric ventricular remodeling (Song, Mihara, Chen, Scorrano, & Dorn, 2015). According to 
this study, Drp1 ablation causes an increase in mitophagy activity, possibly via regulating 
permeability transition pore (mPTP) opening, which contributes to a generalized loss of 
mitochondria. In contrast, the Mfn ablation leads to activation of unfolded protein response 
(UPR) without a proper increase of mitophagy, suggesting that even though mitochondrial fusion 
and fission have opposing roles in cardiac MCQ, interrupting any of these two processes leads to 
cardiac remodeling and dysfunction (Song et al., 2015). Similarly, the heart-specific knockdown 
of Marf (Drosophila mitofusin) or Opa1 induces heart tube dilation and significant contractile 
dysfunction in Drosophila as well (Dorn et al., 2011). Interestingly, Mfn1/Mfn2/Drp1 cardiac 
triple-knockout mice showed partial rescue of myocardial function comparing to fusion-defective 
26 
 
Mfn1/Mfn2 knockout or fission-defective Drp1 knockout mice, indicating that maintaining the 
balance between mitochondrial fusion and fission is essential for cardiac health (Song, Franco, 
Fleischer, Zhang, & Dorn, 2017).  
Despite the recent illumination of the roles and mechanisms of fission and fusion in 
regulating mitochondrial morphology and cardiac health, challenges remain in studying these 
processes in aged cardiac tissue for the reasons that the majority of age-related studies on 
mitochondrial dynamics were conducted in either cultured cardiomyocytes or stress-induced 
hearts instead of aging hearts (Tocchi, Quarles, Basisty, Gitari, & Rabinovitch, 2015). However, 
a few studies in lower organism models have shed light on the connection between mitochondrial 
dynamics and lifespan. For example, studies in yeast showed that inhibiting fission extends 
lifespan, while unopposed fission shortens longevity (Scheckhuber et al., 2007). Similarly, 
studies in C. elegans showed that increased mitochondrial fusion extends lifespan (Chaudhari & 
Kipreos, 2017). Furthermore, long-lived C. elegans exhibits elongated mitochondrial network 
and less mitochondrial ROS production, whereas inhibiting mitochondrial fusion in those long-
lived animals reduces their lifespan to wildtype levels, suggesting that mitochondrial fusion is 
necessary, even though not sufficient, for the longevity of those worms with long-lived 
mutations (Chaudhari & Kipreos, 2017). However, mitochondrial fission seems to regulate 
longevity and cardiac aging in a more complex way, and the mechanisms are not well-
understood. The activities of several proteins involved in mitochondrial fission have shown 
reduce with age (Sharma, Smith, Yao, & Mair, 2019). As mentioned earlier, mitochondrial 
fission is closely related to mitophagy, and this notion may be echoed by the fact that mitophagy 
decreases in aging as well (Diot, Morten, & Poulton, 2016). Since mitophagy is essential for the 
clearance of damaged mitochondria and is crucial to stress adaptation, moderately sustained 
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fission stimulation should protect against aging via activating mitophagy. Indeed, Rana and 
colleagues found that short-term induction of Drp1 in midlife, but not earlier in life, extended 
both the healthspan and lifespan of Drosophila, possibly through upregulating mitophagy (Rana 
et al., 2017). However, several other studies suggested that excessive mitochondrial fission and 
unchecked mitophagy, at least partially, contribute to the development of cardiac aging, whereas 
inhibiting excessive fission was suggested to provide cardio-protection under pathological stress. 
For example, over-expression of Tmen135, a novel mitochondrial fission regulator, induces 
mitochondrial fragmentation and hypertrophy and exhibits similar gene expression patterns to 
those found in aging (Lewis et al., 2018). Conversely, inhibition of mitochondrial fission by 
Mdivi-1 after introducing myocardial ischemic insults exerts a cardio-protection effect  
(Maneechote et al., 2018). In summary, mitochondrial fusion and fission are both involved in 
regulating cardiac aging even though the effects may be model-dependent. Most importantly, a 
delicate balance between mitochondrial fusion and fission is the key to affect the longevity and 
how well the heart maintain its function under pathological stresses such as aging (Byrne et al., 
2019; H. Chen et al., 2015).  
Mitophagy 
Mitophagy is a selective autophagy that eliminates damaged or superfluous mitochondria, 
which can be classified into two mechanisms, ubiquitin-dependent, and mitochondrial receptor-
mediated mechanisms, depending on whether ubiquitin is required for cargo recognition. PINK1 
(PTEN-induced putative kinase protein 1) and Parkin are two major mediators involved in 
ubiquitin-dependent mitophagy. Under normal conditions, PINK1 seems to be continuously 
expressed and imported into all mitochondria, followed by rapid degradation via proteolysis. 
Therefore, the level of PINK1 is maintained at deficient levels. However, in response to stresses, 
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PINK1 proteolysis is inhibited, allowing the accumulation of PINK1 only on the surface of 
damaged mitochondria. PINK1 subsequently recruits and activates E3 ubiquitin ligase Parkin, 
which ubiquitinates OMM proteins to trigger and amplify different molecular signals such as 
cytosolic autophagy machinery to facilitate mitochondrial removal (T. N. Nguyen, Padman, & 
Lazarou, 2016; Youle & Narendra, 2011). Additionally, mitochondrial receptor-mediated 
mitophagy activates in response to cellular differentiation cues (Drake, Springer, Poole, Kim, & 
Macleod, 2017) or other specific stresses such as hypoxia, nutrient stress, and 
ischemia/reperfusion (I/R) (H. Zhou et al., 2018). OMM proteins, such as BCL-2-like protein13 
(BCL2L13), NIX, BNIP3, and FUNDC1, then serve as mitophagy receptors to interact with 
autophagosomes to promote mitochondrial degradation (Gatica, Lahiri, & Klionsky, 2018; 
Rogov et al., 2017).  
Mitochondrial dynamics are closely related to mitophagy as well. For example, 
mitofusins are degraded via Parkin-mediated ubiquitination. Therefore the mitophagy is 
facilitated via inhibiting mitochondrial fusion and promoting mitochondrial fragmentation (Gegg 
et al., 2010). Moreover, PINK1 upregulates DRP1 activity during mitophagy by inhibiting PKA-
mediated DRP1 phosphorylation, resulting in mitochondria segregation. Indeed, evidence 
suggested that mitochondrial fission is a prerequisite for mitophagy induction (Gomes, Di 
Benedetto, & Scorrano, 2011; Kageyama et al., 2014; Twig et al., 2008), which also seems 
physiologically favorable since smaller mitochondria can be autophagocytosed easily at a lower 
cost of energy than the larger ones (Seo et al., 2010). However, some mitophagy forms, such as 
hypoxia-induced mitophagy, is thought to be independent of mitochondrial fission (Yamashita et 
al., 2016).  
29 
 
It is generally accepted that mitophagy activity decreases with age, contributing to the 
accumulation of dysfunctional mitochondria and several age-related diseases. Mitochondrial 
fragmentation and basal mitophagy decline have been observed in aging hearts as well (Stotland 
& Gottlieb, 2016). Similarly, proteins involved in MQC, such as PINK1 and the mitochondrial 
biogenesis regulator PGC-1α, decrease in aged mice hearts (J. Zhou et al., 2017). In line with 
these findings, a recent study showed that, during differentiation process, NIX and FUNDC1-
mediated mitophagy can be disrupted by age-induced mtDNA mutation in adult cardiac 
progenitor cells, which resulted in sustained mitochondrial fission, the formation of amorphic 
mitochondria, and ultimately increased susceptibility to cell death (Lampert et al., 2019). On the 
other hand, interventions that boost mitophagy in multiple aging models have shown some 
beneficial effects. For example, the treatment of urolithin A, a mitophagy inducer, has been 
shown to prolongs lifespan and improve physical exercise capability in C. elegans (Ryu et al., 
2016). In aged mice, urolithin A treatment also diminishes age-induced muscle function decline. 
In Drosophila, increased mitophagy by parkin overexpression leads to lifespan extension and 
decreased protein aggregation (Rana, Rera, & Walker, 2013).  
However, mitophagy may also exert unfavorable effects on the heart. For instance, G 
protein-coupled estrogen receptor 1 (GPER) offers cardio-protection against I/R injury by 
reducing mitophagy in rats (Y. Feng, Madungwe, da Cruz Junho, & Bopassa, 2017). Inhibiting 
PINK1/Parkin-mediated mitophagy might slow AGEs (Advanced glycation end products)-
induced cardiac aging by reducing cardiomyocyte senescence (Zha, Wang, Wang, Lu, & Guo, 
2017). Recently, Zhou and colleagues found that increased mitochondrial permeability might 
explain why elevated mitophagy/autophagy is harmful in specific contexts (B. Zhou et al., 2019). 
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Additionally, the different levels, types, duration of mitophagy, and the time points to introduce 
the treatment might also contribute to different effects of mitophagy on cardiac aging.  
1.3.4 Mitochondrial ER Contact 
As energy centers, mitochondria regulate a wide range of cellular functions not only 
through its own regulation but also through a finely tuned interplay with other organelles, such as 
the ER, peroxisomes, and nucleus (M. Xia et al., 2019). Recently, MAMs that connects 
mitochondria and ER have become a hot topic in biological research for the reason that MAMs 
serve as a key signaling hub for extensive cellular function such as biosynthesis, immune 
response, energy metabolism, and cell turnover (M. Xia et al., 2019). Moreover, the crosstalk 
between mitochondria and ER is a prerequisite for healthy cardiac function (J. Li et al., 2019). 
This section summarizes the critical role of MAMs and their association with cardiac aging.  
Ca2+ transfer 
One of the first functions established for MAMs is Ca2+ transfer. Both mitochondria and 
ER store a large amount of Ca2+ in the cell, and Ca2+ could release from ER to mitochondria. 
Therefore, the formation of microdomains of high Ca2+ concentration in MAMs is crucial to 
promote mitochondrial Ca2+ uptake. Under the action of the calcium channel IP3R and other 
signaling in MAMs, Ca2+ is quickly released from the ER into the cytosol around the 
mitochondria (Berridge, 2016). Ca2+ then diffuses across OMM via the voltage-dependent anion 
channels (VDAC) and passes through IMM mainly via the mitochondrial calcium uniporter 
(MCU) receptor (Chaudhuri, Sancak, Mootha, & Clapham, 2013; Morciano et al., 2018). Ca2+ 
transfer becomes efficient when ER is near mitochondria, whereas the increasing distance 
between mitochondria and ER can terminate the Ca2+ transfer (Csordás et al., 2010). As further 
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detail of the formation of MAMs is reviewed in a later section, MFN2 is an essential physical 
tether between ER and mitochondria, which enables Ca2+ signaling between these two organelles 
(de Brito & Scorrano, 2008). In addition to MFN2, several other proteins, including GRP75, 
FIS1, VAPB, PTPIP51, BAP31, and PDZD8 are involved in establishing interaction between 
mitochondria and ER, therefore to regulate Ca2+ exchange and other functions as well 
(Gordaliza-Alaguero, Cantó, & Zorzano, 2019). Additionally, since mitochondrial Ca2+ levels 
control the activities of several dehydrogenases in Krebs cycles, the Ca2+ transfer from ER to 
mitochondria is also crucial for mitochondrial energy metabolism. Indeed, mitochondrial 
respiration and bioenergetics can be promoted by enhanced ER-mitochondrial coupling during 
early phase of ER stress (Bravo et al., 2011). Beyond mitochondria bioenergetics, mitochondrial 
Ca2+ also regulates apoptosis. For example, under oxidative stress, excessive mitochondrial Ca2+ 
promotes mPTP opening and apoptotic factors releasing into the cytoplasm (Baumgartner et al., 
2009).  
Mitochondrial dynamics 
MAMs play essential roles in the regulation of mitochondrial dynamics as well. Friedman 
and colleagues found that mitochondrial division always occurs at positions where ER tubules 
make contact with mitochondria. With the help of several ER proteins, ER tubules physically 
wrap around and constrict mitochondria to a diameter close to the diameter of DRP1 helices, 
facilitating the DRP1 recruitment and mitochondrial fission (Friedman et al., 2011b). 
Mitochondrial dynamics, on the other hand, also regulate communication between ER and 
mitochondria. The mitochondrial fusion protein MFN2 is enriched in MAM, where it can 
interact with mitofusin on mitochondria to form an inter-organellar bridge. In line with this 
finding, Chen and colleagues showed that cardiac-specific ablation of MFN2 resulted in 30% 
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less ER-mitochondrial tethering, which caused decreased mitochondrial Ca2+ uptake and 
impaired stress response (Y. Chen et al., 2012). Interestingly, both mitochondrial fission and 
Ca2+ transfer require proximity between ER and mitochondria, suggesting that crosstalk exists 
between calcium signaling and mitochondrial fission. Indeed, Thapsigargin (TG) -induced 
mitochondrial Ca2+ uptake has been shown to cause mitochondrial fragmentation in rat liver cells 
(J. R. Hom, Gewandter, Michael, Sheu, & Yoon, 2007). Moreover, TG also promotes 
mitochondrial fragmentation in rat ventricular myocytes by inducing global cytosolic Ca2+ and 
promoting DRP1 colocalization from the cytosol to mitochondria (J. Hom, Yu, Yoon, Porter, & 
Sheu, 2010). Meanwhile, mitochondrial Ca2+ uptake is also regulated by mitochondrial shape 
and positioning. For instance, a previous study showed the Drp1 deficiency induces 
mitochondrial Ca2+ overload by increasing the MCU expression (Favaro et al., 2019).   
Unfolded protein response (UPR) 
In response to stress, such as proteotoxic stress, oxidative stress, or loss of Ca2+ 
homeostasis, the accumulation of unfolded proteins in the ER activates the ER stress response. 
The ER UPR (UPRER) is a major ER stress response, which inhibits protein synthesis and 
enhances the folding capacity and degradation capacity of ER (Schröder & Kaufman, 2005). 
Under normal conditions, three arms of UPRER, activating transcription factor 6 (ATF6), 
inositol-requiring transmembrane kinase/endoribonuclease 1 (IRE1), and protein kinase RNA-
like endoplasmic reticulum kinase (PERK), are bound to GRP78 (Bertolotti, Zhang, Hendershot, 
Harding, & Ron, 2000). However, the cellular stress can activate these three arms by promoting 
GRP78 dissociation from ATF6, IRE1, and PERK, thereby initiating the transcription of ER-
related molecular chaperones and folding catalysts (J. Li et al., 2019). Similarly, the 
accumulation of unfolded proteins in mitochondria could activate mitochondrial UPR (UPRmt) as 
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well (Q. Zhao et al., 2002). Activated UPRmt functions through ATF5, PERK, and JNK2, which 
initiate the transcription of mitochondrial proteases, mitochondrial molecular chaperons, and 
proteins involved in mitochondrial import and ROS detoxification (Qureshi, Haynes, & 
Pellegrino, 2017). However, it is noteworthy that even though UPRER exerts some adaptive 
effects to restore ER homeostasis during the early phase of stress conditions by removing 
unfolded or damaged proteins, chronic or over-activation of UPRER could lead to apoptosis, 
which could be detrimental to the non-regenerative cells such as cardiomyocytes.  
Since ER is physically and functionally connected to mitochondria, the inter-organelle 
communication between ER and mitochondria is inevitable upon the activation of UPRER/UPRmt 
under stress conditions. Indeed, the activities of various MAM proteins have shown increased 
under ER stress. For example, the expression RAB32, a GTPase regulates ER-mitochondria 
interactions (Bui et al., 2010), is upregulated upon brain inflammation or in the neuroblastoma 
cells treated with ER stress inducers (Haile et al., 2017; Liang et al., 2012). Besides, the 
expression of other MAM regulatory proteins, including MFN2, GRP72, and PACS2, are all 
upregulated under brain inflammation (Haile et al., 2017). In addition, Mfn2-deficiency further 
induces three arms of UPR under ER stress in mouse embryonic fibroblasts, suggesting a unique 
role of MFN2 in regulating UPR (Muñoz et al., 2013). Indeed, evidence suggests that MFN2 
physically interacts with and represses PERK in the absence of ER stress (Muñoz et al., 2013). 
On the other hand, PERK also plays a role at MAMs, allowing the transfer of ROS-mediated 
signals between the ER and mitochondria (Verfaillie et al., 2012). Collectively, MAMs enable 
bidirectional communication between ER and mitochondria under stress conditions.  
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Mitochondria-ER contact and CVD 
Due to the importance of MAMs in regulating the functions mentioned above, the 
interaction between the ER and mitochondria plays a fundamental role in cardiac aging and 
diseases. Extensive evidence suggests that alteration of the interaction between the ER and 
mitochondria contributes to age-related cardiac dysfunction, especially via impairment of 
autophagy, apoptosis, Ca2+ handling, and mitochondrial functions, even though the molecular 
mechanisms of this age-related alteration still remain unclear (Fernandez-Sanz et al., 2014; J. Li 
et al., 2019; Nuss, Choksi, DeFord, & Papaconstantinou, 2008).  Specifically, deregulated Ca2+ 
handling between ER and mitochondria leads to mitochondrial Ca2+ overload, which 
subsequently induces the chance of developing cardiac I/R injury. Conversely, reducing the 
mitochondria-ER interaction in the ischemic heart protects it from lethal reperfusion injury 
(Paillard et al., 2013). However, disrupting MAMs formation via ablating MAM proteins such as 
GRP78 under normal conditions results in cardiac cell death and cardiac dysfunctions (Xiaoding 
Wang et al., 2018). Additionally, altered interaction between the ER and mitochondria also 
contributes to metabolic disorders in heart, such as the development of diabetic cardiomyopathy. 
Evidence suggests that the formation of MAMs and mitochondrial Ca2+ influx are significantly 
increased in diabetic, obese, or HFD-fed mice, which further leads to mitochondrial and cardiac 
dysfunctions (Arruda et al., 2014; S. Wu et al., 2019).  
Taken together, an imbalance between the interaction between the ER and mitochondria 
may contribute to cardiac dysfunctions, which increases the vulnerability of the heart to the 
aging process.  
In summary, the alteration in 1) longevity pathways, such as IGF-1/insulin signaling, 
MTOR signaling; 2) quality control machinery, such as autophagy and MQC processes; and 3) 
systemic inter-organellar communication, such as mitochondria-ER contacts, all contribute to the 
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development of CVDs during aging. Understanding the mechanisms of age-related regulation of 
the above processes could provide novel insights and therapeutic strategies to improve 
cardiovascular function during aging.  
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2.1 Abstract 
Age-related impairment of macroautophagy/autophagy and loss of cardiac tissue 
homeostasis contribute significantly to cardiovascular diseases later in life. MTOR (mechanistic 
target of rapamycin kinase) signaling is the most well-known regulator of autophagy, cellular 
homeostasis, and longevity. The MTOR signaling consists of two structurally and functionally 
distinct multiprotein complexes, MTORC1 and MTORC2. While MTORC1 is well characterized 
but the role of MTORC2 in aging and autophagy remains poorly understood. Here we identified 
TGFB-INHB/activin signaling as a novel upstream regulator of MTORC2 to control autophagy 
and cardiac health during aging. Using Drosophila heart as a model system, we show that 
cardiac-specific knockdown of TGFB-INHB/activin-like protein daw induces autophagy and 
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alleviates age-related heart dysfunction, including cardiac arrhythmias and bradycardia. 
Interestingly, the downregulation of daw activates TORC2 signaling to regulate cardiac 
autophagy. Activation of TORC2 alone through overexpressing its subunit protein rictor 
promotes autophagic flux and preserves cardiac function with aging. In contrast, activation of 
TORC1 does not block autophagy induction in daw knockdown flies. Lastly, either daw 
knockdown or rictor overexpression in fly hearts prolongs lifespan, suggesting that manipulation 
of these pathways in the heart has systemic effects on longevity control. Thus, our studies 
discover the TGFB-INHB/activin-mediated inhibition of TORC2 as a novel mechanism for age-
dependent decreases in autophagic activity and cardiac health. 
2.2 Introduction 
Aging is associated with an exponential increase in the incidence of cardiovascular 
diseases (CVD) (Dai, Chen, Johnson, Szeto, & Rabinovitch, 2012; North & Sinclair, 2012). Age-
related changes in cardiovascular structure and output have been linked to increased risk of 
coronary heart disease, sudden cardiac death and stroke in the elderly population (Lakatta & 
Levy, 2003). During normal aging, the left ventricular wall of human hearts becomes thickened 
and the diastolic filling rate of left ventricle gradually decreases, while the left ventricular 
systolic performance at rest remains no change with age (Lakatta & Levy, 2003). Several 
mechanisms underlying these age-associated changes in cardiovascular structure and function 
have been proposed, for example, changes in growth factor signaling, decreased cellular quality 
control, altered calcium handling, elevated extracellular matrix deposition or fibrosis, increased 
mitochondria damage, and the production of reactive oxygen species (ROS) (North & Sinclair, 
2012). Resolving the contributing mechanisms underlying the age-dependent decline of 
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cardiovascular function is critical for the development of therapeutic interventions for the 
treatment of cardiovascular diseases. 
Cellular quality control systems, such as macroautophagy (hereinafter referred to as 
autophagy), are essential to the maintenance of tissue homeostasis during aging (Rubinsztein, 
Marino, & Kroemer, 2011). Autophagy is a highly conserved process that is responsible for the 
degradation and recycling of damaged organelles, protein aggregates, and other cytoplasmic 
substances (Shibutani & Yoshimori, 2014). It is generally accepted that autophagy activity 
declines with age (Chang, Kumsta, Hellman, Adams, & Hansen, 2017). However, how 
autophagic activity is altered in aging hearts remains unclear. Disruption of autophagy pathways 
often leads to loss of tissue homeostasis and tissue dysfunction. For example, knocking out 
autophagy gene Atg5 in the mouse heart accelerates cardiac aging, including an increase in left 
ventricular hypertrophy and decrease in fractional shortening (Taneike et al., 2010). As a key 
autophagy regulator, MTOR (mechanistic target of rapamycin kinase) plays an important role in 
the regulation of cardiac tissue homeostasis (North & Sinclair, 2012). The MTOR signaling 
consists of two structurally and functionally distinct protein complexes, MTORC1 and MTORC2 
(Saxton & Sabatini, 2017). Rapamycin-mediated suppression of MTORC1 induces autophagy 
and protects mouse cardiomyocytes from oxidative stress (Dutta, Xu, Kim, Dunn, & 
Leeuwenburgh, 2013). Drosophila genome contains evolutionarily conserved Tor kinase and 
several major TOR complex subunits (e.g., RAPTOR and Lst8 for TORC1, rictor, Sin1 and Lst8 
for TORC2) (Takahara & Maeda, 2013). Drosophila MTORC1 promotes electrical pacing-
induced heart failure (Wessells et al., 2009), and high-fat-diet-induced cardiomyopathy (Birse et 
al., 2010). Unlike MTORC1, the role of MTORC2 in autophagy, tissue homeostasis, and cardiac 
aging remains poorly understood. Two recent studies show that disruption of MTORC2 subunit 
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RICTOR (RPTOR independent companion of MTOR complex 2) induces cardiac dysfunction in 
mice (Sciarretta et al., 2015; Shende et al., 2016). Interestingly, 2 MTOR complexes exhibit 
distinct regulation on lifespan. Inhibition of MTORC1 is known to prolong lifespan (Kaeberlein 
et al., 2005), while deletion of RICTOR, the key component of MTORC2, shortens lifespan of 
male mice (Lamming et al., 2014). However, the molecular basis for MTORC2-regulated aging 
and tissue homeostasis remains to be further examined. 
TGFB (transforming growth factor beta) is an evolutionarily conserved signaling 
pathway that regulates a wide variety of cellular processes, such as proliferation, differentiation, 
apoptosis, inflammation, and fibrosis (Upadhyay, Moss-Taylor, Kim, Ghosh, & O'Connor, 
2017). Recent studies demonstrate that TGFB factors promote cardiac fibrosis during aging 
(Biernacka & Frangogiannis, 2011), while reduction of TGFB signaling improves cardiac health 
in aged mice through the regulation of microRNA MIR29 (Lyu et al., 2018). As in mammals, 
TGFB family in Drosophila has 2 major branches, BMP (bone morphogenetic protein) and 
TGFB-INHB/activin signaling pathways (Upadhyay et al., 2017). In both TGFB pathways, 
signaling starts with ligand binding to a receptor complex composed of type I and type II 
receptor kinases, followed by phosphorylation of receptor-activated SMAD (R-SMAD). 
Recently, we and other groups show that TGFB-INHB/activin signaling regulates muscle 
proteostasis and longevity in Drosophila (Bai, Kang, Hernandez, & Tatar, 2013; Demontis, 
Patel, Swindell, & Perrimon, 2014). However, it remains to be determined whether TGFB family 
proteins, in particular, INHB/activin, regulate cardiac homeostasis and function.  
While investigating the role of Drosophila TGFB-INHB/activin signaling in the 
regulation of autophagy and age-related cardiomyopathy, we find that TGFB-INHB/activin 
signaling genetically interacts with TORC2, but not TORC1 to control age-dependent decreases 
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in autophagy and cardiac health. We further show that the activation of TORC2 alone can induce 
autophagy and preserve cardiac function during aging. Thus, our studies uncover a novel 
crosstalk between TGFB-INHB/activin signaling and TORC2 that is essential for the 
maintenance of autophagic activity, tissue homeostasis, and cardiac health with aging.   
2.3 Results 
2.3.1 Heart-specific Knockdown of TGFB-INHB/activin-like Ligand Daw Slows Cardiac 
Aging. 
Our previous study demonstrated that the TGFB-INHB/activin-like protein daw regulates 
tissue homeostasis (especially in indirect flight muscle) and longevity in Drosophila (Bai et al., 
2013). Interestingly, we found that the mRNA expression of daw was significantly upregulated 
in aging fly hearts (29.7-fold) (Fig. 1A), suggesting that TGFB-INHB/activin signaling may play 
a role in regulating cardiac aging. To investigate this possibility, we knocked down the 
expression of daw specifically in the heart with a binary GAL4/UAS system where we crossed 
UAS-daw RNAi lines into a cardiac-specific tissue driver (Hand-gal4 or Hand4.2-gal4) (Fig. 
S1A and S1B). We analyzed cardiac performance in young and old flies using a high-speed 
video imaging system (semi-automatic optical heartbeat analysis, SOHA) (Fink et al., 2009). M-
Mode traces from the SOHA analysis indicated that knockdown of daw preserved cardiac 
contractility at advanced ages (Fig. 1B). In wild-type flies, aged hearts showed increased 
arrhythmia (Fig. 1C, S1I and S1J, data from three wild-type genotypes), lengthened diastolic 
intervals and heart period (bradycardia, slow heart rate) (Figs. 1D and 1E), and decreased 
cardiac output (Fig. 1F). Systolic intervals normally remain unchanged (Fig. S1E). There is a 
small age-related reduction in fractional shortening (Fig. S1F), but the diastolic and systolic 
diameters were not significantly altered (Fig. S1G and S1H). Interestingly, cardiac-specific 
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knockdown of daw attenuated the age-dependent increase in arrhythmia, diastolic intervals, and 
heart period (Fig. 1C-1E). Knockdown of daw also maintained relatively normal cardiac output 
at advanced ages (Fig. 1F). Similar results were observed from three independent daw RNAi 
lines (the knockdown efficiency of daw RNAi was verified by qRT-PCR previously (Bai et al., 
2013), as well as reconfirmed in the present study) (Fig. S1C and S1D). However, cardiac-
specific overexpression of daw did not lead to premature cardiac aging phenotypes (Fig. S1K), 
which may be because the ectopic expression of daw in the heart did not generate active daw 
proteins. 
The Hand-gal4 line drives gene expression in both cardiomyocytes and pericardial cells 
(Fig. S1A). To test the cardiomyocyte-specific role of daw in cardiac aging, we then crossed daw 
RNAi into a cardiomyocyte-specific driver tinc-gal4 (or tincΔ4-gal4) (Fig. S1A). Similar to the 
results from Hand-gal4 (Fig. 1C and 1G), cardiomyocyte-specific knockdown of daw prevented 
the age-related increase in cardiac arrhythmia (Fig. 1H). We also tested whether daw expression 
in pericardial cells can regulate cardiac aging using a pericardial cell-specific driver 
Ugt36A1/Dot-gal4. Interestingly, knockdown of daw in pericardial cells also alleviated age-
induced arrhythmia (Fig. 1I), but not diastolic interval (Fig. 1J). Thus, reduction of daw 
signaling can alleviate age-related cardiac dysfunction, particularly the age-induced arrhythmia, 
through both cardiomyocyte-specific regulation and non-autonomous signaling from pericardial 
cells.  
It is known that TGFB-INHB/activin signaling typically functions through its 
downstream transcription factor SMAD2 (or Smox in Drosophila). We noticed that during aging 
the phosphorylation of Smox/SMAD2 was elevated in the fly heart nuclei (Fig. 1K). To test the 
role of Smox in cardiac aging, we performed SOHA analysis on flies with cardiac-specific Smox 
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knockdown. Surprisingly, knockdown of Smox in the heart did not attenuate the age-dependent 
increase in arrhythmia, diastolic intervals, and heart period (Fig. 1L). These findings suggest that 
daw may regulate cardiac aging through a Smox-independent pathway (e.g., MAPK/p38 
signaling (Hu et al., 2016)). 
2.3.2 Cardiomyocyte-specific Knockdown of INHB/activin Receptor Babo Delays Cardiac 
Aging. 
In Drosophila, INHB/activin-like ligand daw signals through the type I receptor babo, the 
fly homolog of mammalian ACVR1B/ALK4 (activin A receptor, type 1B) (Upadhyay et al., 
2017). To investigate whether daw acts through its receptor babo to modulate cardiac aging, we 
first tested if babo plays a similar role in preventing the age-dependent increase in 
cardiomyopathy. Consistent with the results from daw knockdown, we found that 
cardiomyocyte-specific knockdown of babo blocked the age-related increase in cardiac 
arrhythmia, diastolic intervals, and heart period (Fig. 2A-2C). Two independent babo RNAi 
lines were used and both gave similar results (the knockdown efficiency of babo RNAi was 
verified by qRT-PCR in our previous study (Bai et al., 2013). Knockdown of babo did not affect 
age-dependent changes in cardiac output (Fig. S1L), which may be attributed to the similar 
diastolic diameter and systolic diameter between wild-type and babo knockdown flies (Fig. S1M 
and S1N). These results suggest that babo and daw regulate both common and distinct aspects of 
cardiac function.  
In a reciprocal experiment, we used a GeneSwitch heart driver (Hand-GS-gal4) to 
express a constitutively active form of babo (baboAct, or baboQ302D) specifically in adult hearts. 
GeneSwitch heart driver was used because constitutively expressing active babo in the heart 
(Hand>baboAct) led to severe developmental arrest at pupal stages (data not shown). We found 
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that cardiac expression of activated babo significantly increased cardiac arrhythmia, diastolic 
intervals, and heart period already at young ages (Fig. 2D-2F). Taken together, these results 
suggest that INHB/activin type I receptor babo plays an important role in age-related 
cardiomyopathy, especially cardiac arrhythmia, diastolic function, and heart rate.  
2.3.3 Daw Negatively Regulates Autophagy in Fly Hearts. 
Autophagy is one of the key mechanisms in maintaining tissue hemostasis, and its 
activity normally declines with age (Chang et al., 2017; Rubinsztein et al., 2011; Taneike et al., 
2010). Our previous studies showed that TGFB-INHB/activin signaling regulates 
autophagosome formation and Atg8a transcription in Drosophila flight muscle (Bai et al., 2013). 
It is likely that daw regulates cardiac aging by modulating autophagic activity. To first verify the 
role of daw in autophagy-lysosome activity, we used LysoTracker staining, a well-established 
autophagy marker in flies (Scott, Schuldiner, & Neufeld, 2004), to monitor the lysosomal 
acidification in adult fat body. Consistent with our previous finding, heterozygous daw [11] loss-
of-function mutants showed increased LysoTracker staining, suggesting an elevated basal 
autophagy/lysosome activity (Fig. 3A). We furthermore showed that mutation of daw increased 
autophagic flux, indicated by the induction of lipidated Atg8a (Atg8a-II) upon the treatment of 
lysosome inhibitor bafilomycin A1 (BafA1) (Fig. 3B). Atg8a is the fly homolog of mammalian 
LC3-GABARAP family proteins. A rabbit monoclonal antibody for human GABARAP (E1J4E) 
(Barekat et al., 2016; Ratliff, Barekat, Lipinski, & Finley, 2016; Ratliff, Kotzebue, et al., 2016) 
was used in the lipidation assay. The specificity of the antibody has been previously verified 
(Kim et al., 2015) and further confirmed in the present study (Fig. S2, also see Methods).  
Finally, the mosaic analysis revealed that somatic cell clones in larval fat body expressing RNAi 
against either daw or babo (marked by GFP) showed increased numbers of autophagosome, 
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indicated by mCherry-Atg8a-positive puncta (Fig. 3C). These data suggest that TGFB-
INHB/activin signaling negatively regulates autophagy and lysosome activities. 
Next, we examined whether daw plays a similar role in modulating autophagy in fly 
hearts. Immunostaining with GABARAP (E1J4E) antibodies showed that the number of 
autophagosome in the heart was higher in daw [11] mutants compared to wild-type (Fig. S3A and 
S3B). Because autophagy is a dynamic process, the increased number of autophagosome could 
result from elevated autophagy activities, or blockage of lysosomal degradation (Klionsky et al., 
2016). To test these possibilities, we next examined the role of daw in the regulation of 
autophagic flux (the turnover of autophagosome). We exposed semi-intact fly hearts to BafA1, 
the V-ATPase inhibitor that blocks both lysosomal acidification and autophagosome-lysosome 
fusion (Mauvezin, Nagy, Juhasz, & Neufeld, 2015). We found that BafA1 treatment resulted in a 
higher induction in the number of Atg8a-positive autophagosome in daw[11] hearts compared to 
wild-type hearts (Fig. S3A-S3C). Thus, the results suggest that daw negatively regulates 
autophagic flux in fly hearts. 
2.3.4 Knockdown of Daw Preserves Autophagic Activity During Cardiac Aging. 
Aging tissues show reduced autophagy and accumulated cellular damages. We next 
examined whether inhibition of INHB/activin-daw signaling in fly hearts can alleviate age-
dependent deregulation of autophagy. Using a mCherry-Atg8a reporter line, we observed a large 
accumulation of Atg8a-positive autophagosome in aged hearts of wild-type flies (Fig. 3D, 3E, 
3H and 3I). The age-related accumulation of autophagosome was not due to increased 
expression of the cardiac driver. Because both Hand-gal4 and tinc-gal4 drivers showed either 
reduced or no change of expression during aging (Fig. S1A and S1B). In fact, the accumulation 
of autophagosome is likely due to the blockage of autophagosome turnover (autophagic flux), 
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because BafA1 treatment induced Atg8a-positive puncta in young hearts, but not in the old 
hearts (Fig. 3E, 3H, 3I and 3J). To confirm this finding, we monitored autophagosome using an 
alternative method, the immunostaining with GABARAP antibody (Fig. S4A and S4B). We 
observed a similar accumulation of autophagosome in aged hearts, and the autophagic flux was 
also reduced during aging (Fig. S4A and S4B). Furthermore, we found that the receptor protein 
ref(2)P/SQSTM1/p62, a marker for defective aggrephagy (Nezis et al., 2008), was accumulated 
in aging hearts and Atg8a mutants (Fig. S5), suggesting an age-related impairment in 
autophagy/lysosome degradation system. We also tested autophagic flux using mCherry-GFP-
Atg8a tandem reporter. However, we hardly observed any GFP signals in fly hearts, even after 
BafA1 treatment (Fig. S4C). This is quite different from fat body tissue, where BafA1 treatment 
significantly induced GFP signals when the tandem reporter was expressed using r4-gal4 (Fig. 
S4D). 
Intriguingly, flies with heart-specific daw knockdown maintained high levels of cardiac 
autophagosome turnover (or active autophagic flux) at both young and old ages, as indicated by 
the induction of autophagosome number upon BafA1 treatment (Fig. 3F, 3H, 3I and 3J). 
Notably, constitutively activated babo suppressed the autophagic flux in both young and old 
hearts (Fig. 3G and 3H). Activation of babo also blocked the age-dependent accumulation of 
autophagosome in old fly hearts (Fig. 3G and 3H), which suggests that besides the regulation of 
autophagosome turnover (degradation), TGFB-INHB/activin signaling also plays an important 
role in autophagosome initiation and formation. Taken together, our findings suggest that 
reduction of INHB/activin-daw signaling promotes autophagosome turnover and preserves 
autophagic activity during cardiac aging. 
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2.3.5 Inhibition of Autophagy, but not Activation of TORC1, Blocks Daw Knockdown-
mediated Cardioprotection. 
Since we observed an induction of autophagy in daw knockdown flies, we next asked 
whether autophagy activity is required for daw-regulated cardiac aging. First, we fed control and 
daw knockdown flies with a lysosomal inhibitor chloroquine (CQ). As expected, CQ treatment 
increased cardiac arrhythmia in daw knockdown flies back to the similar levels seen in old wild-
type flies (Fig. 4A), while CQ treatment is non-toxic and did not lead to any mortality within two 
weeks of feeding (Fig. S5D). To directly test whether autophagy plays any role in daw-regulated 
cardiac aging, we generated double knockdown flies by combining UAS-daw RNAi and UAS-
Atg1 RNAi fly lines. Atg1 is a serine/threonine-protein kinase that is essential for autophagy 
initiation, and has been previously shown to play a role in regulating cardiac function (J. H. Lee 
et al., 2010). Cardiac-specific knockdown of Atg1 increased both cardiac arrhythmia and 
diastolic intervals at young and old ages (Fig. 4B), similar to the fly heart with activated babo 
(Fig. 2D and 2E).  Consistent with CQ treatment, cardiac-specific knockdown of Atg1 
attenuated cardioprotective effects of daw RNAi. Simultaneously knockdown of Atg1 and daw in 
the heart led to an age-dependent increase in arrhythmia similar to control flies (Fig. 4C). Atg1 
knockdown in daw RNAi background also slightly increased arrhythmia at young ages (Fig. 
4C). The knockdown efficiency of daw was not affected by combining daw RNAi and Atg1 
RNAi lines (Fig. S5E). Thus, these results suggest that autophagic activity and Atg1 are required 
for daw-regulated cardiac aging.  
TORC1 is a key negative regulator of autophagy (Fig. S6A) (Scott et al., 2004). We 
found that TORC1 activity, indicated by phosphorylation of Thor/EIF4EBP1, was reduced in 
daw knockdown flies (Fig. S6B). We then tested whether daw could regulate autophagy and 
cardiac aging through TORC1 signaling. If TORC1 acts as a downstream effector of daw to 
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regulate autophagy and cardiac aging, one would expect that activation of TORC1 can attenuate 
daw knockdown-mediated cardiac protection and autophagy induction. To test this possibility, 
we first generated double knockdown flies by combining UAS-daw RNAi and UAS-Tsc1 RNAi. 
Drosophila Tsc1 (TSC complex subunit 1) is a negative regulator of TORC1, knockdown of 
Tsc1 increased the phosphorylation of Thor/EIF4EBP1 in fly hearts (Fig. S6B). The knockdown 
efficiency of Tsc1 is shown in Fig. S6C. Surprisingly, activation of TORC1 via Tsc1 knockdown 
had no effects on cardiac arrhythmia (Fig. 4D), but reduced diastolic intervals at young age (Fig. 
4E), which is very different from the cardiomyopathy resulted from cardiac-specific activation of 
INHB/activin receptor babo (Fig. 2D and 2E). Furthermore, knockdown of Tsc1 did not affect 
the cardioprotective role of daw silencing (Fig. 4F). Simultaneously knockdown of Tsc1 and 
daw showed similar arrhythmia index as daw RNAi alone. In addition, loss-of-function mutant 
Tsc1[12] did not rescue the elevated LysoTracker staining in daw[11] mutants (Fig. 4G). These 
results suggest that activation of TORC1 is not required for daw-regulated autophagy and cardiac 
aging. 
It is known that inhibition of TORC1 prolongs lifespan (Johnson, Rabinovitch, & 
Kaeberlein, 2013; Kaeberlein et al., 2005) and attenuates stress-induced cardiomyopathies (Ding 
et al., 2011; Luong et al., 2006; Shioi et al., 2003; Wessells et al., 2009). However, the specific 
role of TORC1 in cardiac aging is not well understood. Here, we observed unique alternations of 
cardiac function in response to activation of TORC1 (via Tsc1 knockdown), including decreased 
heart period (Tachycardia, fast heart rate), and reduced diastolic intervals (Fig. 4E, S6D and 
S6E) These cardiac functional changes are not the same as age-induced cardiomyopathies, rather 
they resemble high-fat-diet-induced cardiac complications where TORC1 is known to play an 
important role (Birse et al., 2010). Intriguingly, flies with cardiac-specific knockdown of Tsc1 
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showed no age-dependent increases in heart period, diastolic intervals, and arrhythmia (Fig. 
S6D-S6F). Similar cardiomyopathy phenotypes were also observed in other TORC1 activation 
mutants, such as 1) knockdown of REPTOR (Repressed by TOR), a recently identified bZIP 
transcription factor that is negatively regulated by TORC1 (Tiebe et al., 2015) (Fig. S6G-S6I), 
and 2) overexpression of Rheb (Ras Homolog Enriched in Brain), a positive regulator of TORC1 
(Fig. S6J-S6L). Thus, it seems that INHB/activin-daw signaling and TORC1 exhibit different 
effects on cardiac function. 
2.3.6 Daw Genetically Interacts with TORC2 (rictor) to Control Autophagy and Cardiac 
Aging. 
Besides the regulation of p-Thor (Fig. S6B), cardiac-specific knockdown of daw 
increased the phosphorylation of Akt1 (at Ser505) in the heart, the upstream regulator of TORC1 
(Fig. 5A). On the other hand, activated receptor babo decreased cardiac Akt1 phosphorylation 
(Fig. 5B). It is interesting that the p-Akt1 appeared as fluorescence puncta in fly hearts. The p-
Akt1 puncta might be associated with mitochondria, since it has been shown that MTORC2 and 
Akt1 are localized on mitochondria-associated endoplasmic reticulum (ER) membrane (Betz et 
al., 2013). We further confirmed the regulation of Akt1 phosphorylation by TGFB-INHB/activin 
signaling using immunoblotting (Fig. 5C). Although the activation of babo did not alter Akt1 
phosphorylation in western blotting analysis, we think that the lack of changes in Akt1 
phosphorylation might be due to the contamination of adjacent tissue (e.g., fat body). It is known 
that Akt1 can be activated and phosphorylated by two kinases at distinct positions, PDPK1/Pdk1 
(3-phosphoinositide dependent protein kinase 1) at Thr308 and MTORC2 at Ser473 (Ser505 in 
flies) (Sarbassov, Guertin, Ali, & Sabatini, 2005). Cardiac-specific overexpressing rictor can 
also induced Akt1 phosphorylation (Fig. 5D). Interestingly, knockdown of daw and babo 
76 
 
upregulated the mRNA expression of rictor in fly hearts (Fig. 5E). These results suggest that 
INHB/activin-daw is a negative regulator of MTORC2 (rictor). 
Unlike TORC1, the role of TORC2 in the regulation of autophagy is unclear. 
Intriguingly, we found that loss-of-function mutants rictor[42] suppressed the high lysosomal 
activities in daw[11] mutants (Fig. 5F and 5G). Similarly, mutations in Sin1, another core 
component of TORC2, blocked the elevated LysoTracker staining in daw mutants (Fig. S7A and 
S7B). Cardiac-specific knockdown of either rictor or Akt1 attenuated the induction of 
autophagosome formation by daw RNAi in fly hearts (Fig. 5H). Furthermore, the mosaic 
analysis revealed that overexpression of rictor induced lysosome activity (Fig. 5I) and increased 
the number of Atg8a-positive autophagosome in fat body (Fig. 5J). Interestingly, unlike Tsc1 
mutants, rictor[42] did not suppress starvation-induced LysoTracker staining (Fig. S7C). 
Similarly, activated TGFB/activin signaling (baboAct) did not block starvation-induced lysosome 
activity (Fig. S7D). Taken together, these data suggest that TGFB-INHB/activin signaling and 
TORC2 (rictor) regulate autophagy differently from TORC1, and rictor acts downstream of 
TGFB-INHB/activin signaling in the regulation of autophagy.  
Lastly, we noticed that the levels of p-Akt1 decreased in aging hearts (Fig. 6A), while 
overexpression of rictor induced autophagic flux in old fly hearts (Fig. 6B). Given that rictor 
positively regulates autophagy, we predict that rictor is a cardiac protective factor. Indeed, 
cardiac-specific overexpression of rictor prevented age-related increases in diastolic intervals 
and arrhythmia (Fig. 6C and 6D), while knockdown of rictor induced arrhythmia, especially at 
old ages (Fig. 6E). Knockdown of rictor also attenuated the cardioprotection by daw RNAi (Fig. 
6F). Furthermore, overexpression of rictor attenuated the elevated diastolic intervals and 
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arrhythmia in fly hearts with constitutively activated babo (Fig. 6G-6I), suggesting that fly 
TGFB/activin signaling regulates cardiac aging through TORC2 (rictor) (Fig. 6J). 
2.3.7 Cardiac-specific Reduction of INHB/activin-daw and Overexpression of Rictor 
Prolong Lifespan.  
Tissue-specific hormonal signaling in systemic aging control has been previously 
reported (Demontis & Perrimon, 2010; Hwangbo, Gershman, Tu, Palmer, & Tatar, 2004; G. 
Zhang et al., 2013). However, whether prolonged organismal lifespan can be achieved by 
maintaining healthy hearts remains less clear. Here we tested the effects of cardiac-specific 
knockdown of INHB/activin signaling in longevity control. Knockdown of daw in the heart 
using two cardiac tissue drivers (tinc-gal4 and Hand-gal4) significantly prolongs lifespan (36.2% 
and 23.2% extension of mean lifespan compared to control lines) (Fig. 7A, 7B and 7D). Because 
daw is a hormonal factor, it remains to be determined whether daw regulates lifespan through 
cell-autonomous or non-autonomous mechanisms. Interestingly, cardiac-specific overexpression 
of rictor also extended lifespan (12% extension of mean lifespan) (Fig. 7C and 7D). Together, 
our findings suggest that cardiac-specific INHB/activin-daw and TORC2 (rictor) signaling 
pathways play important roles in regulating autophagy, cardiac health, as well as longevity. 
2.4 Discussion 
TGFB signaling plays vital roles in a wide range of human diseases, including cancer and 
cardiovascular diseases (Akhurst & Hata, 2012). Originally identified as a reproductive hormone, 
INHB/activin, a TGFB subfamily member, has become an emerging target for the treatment of 
many human diseases (Tsuchida et al., 2009). In the present study, we discover a novel crosstalk 
between TGFB-INHB/activin and TORC2 in the regulation of autophagy and cardiac aging in 
78 
 
Drosophila. Similar to our previous study in Drosophila flight muscle (Bai et al., 2013), 
reduction of TGFB-INHB/activin signaling alleviates age-related cardiac dysfunction, mainly 
through the regulation of cardiac autophagic activity. Mutant daw flies exhibit high autophagic 
flux and elevated lysosome activities. Importantly, we show that activation of TORC1 does not 
block daw knockdown-mediated cardioprotective effects. Instead, INHB/activin-daw signaling 
interacts with TORC2 subunit rictor to regulate autophagy and cardiac function. Activation of 
TORC2 alone can promote cardiac autophagy and maintain cardiac function at old ages. Taken 
together, our studies identify TGFB-INHB/activin signaling as a novel upstream regulator of 
TORC2, and INHB/activin-mediate inhibition of TORC2 might be a novel mechanism for age-
related autophagy impairment and cardiomyopathy.        
Although previous studies have linked TGFB family proteins to longevity regulation (Bai 
et al., 2013; Demontis et al., 2014; Shaw, Luo, Landis, Ashraf, & Murphy, 2007), the role of 
TGFB-INHB/activin signaling in cardiac aging is still not well understood. It has been shown 
that INHBA/ACTIVIN A serum levels significantly increase with age (Baccarelli et al., 2001). 
The mRNA expression of INHBA/ACTIVIN A, as well as serum INHBA/ACTIVIN A levels are 
positively correlated with heart failure (Wei et al., 2013; Yndestad et al., 2004), and hypertension 
in the elderly (Tsai et al., 2017). These findings suggest that activation of TGFB-INHB/activin 
signaling at old ages might be detrimental to the heart. It is known that INHBA/ACTIVIN A 
promotes cardiac fibrosis and myocardial damage after ischemia reperfusion (Y. Chen et al., 
2014). Consistently, mice with heterozygous mutations of ACVR1B/ALK4 are protected from 
pressure overload-induced fibrosis and dysfunction (Y. H. Chen et al., 2017; C. Y. Li et al., 
2016). Inhibition of TGFBR1/ALK5 also reduces myocardial infarction-induced systolic 
dysfunction and left ventricular remodeling in rats (Tan, Zhang, Connelly, Gilbert, & Kelly, 
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2010). However, other studies suggest that INHBA/ACTIVIN A protects hearts from 
hypoxia/reoxygenation- and ischemia/reperfusion-induced cell death (Oshima et al., 2009), even 
though it can promote cardiac apoptosis at higher concentrations (Liu, Mao, Li, Han, & Yang, 
2017). The findings from our study support the detrimental effects of TGFB-INHB/activin 
signaling in cardiac function at old ages. This is consistent with the pro-aging action of TGFB 
and INHB/activin (Bai et al., 2013; Shaw et al., 2007). In addition, our results also suggest that 
daw-regulated cardiac aging through a Smox/SMAD2-independent pathway (Fig. 1). 
TGFB-INHB/activin signaling has been implicated in the regulation of a wide range of 
cellular processes, including cell death and proliferation, inflammation, fibrosis, and metabolic 
homeostasis (Chng, Bou Sleiman, Schupfer, & Lemaitre, 2014; Ghosh & O'Connor, 2014; 
Tsuchida et al., 2009; Werner & Alzheimer, 2006). The role of TGFB-INHB/activin signaling in 
the control of autophagy, a key tissue maintenance process, has only been carefully characterized 
recently (Bai et al., 2013; Florez-McClure & Link, 2009; Xue et al., 2016). In Caenorhabditis 
elegans, the reduction of INHB/activin-like protein DAF-7 suppresses beta-amyloid peptide-
induced autophagosome accumulation (Florez-McClure & Link, 2009). Another recent study 
found that INHBA/ACTIVIN A blocked oxygen-glucose deprivation-induced autophagy through 
the inhibition of MAPK8/JNK and MAPK14/p38 MAPK pathways in neuronal PC12 cells (Xue 
et al., 2016). Our previous studies show that knockdown of Drosophila INHB/activin-like 
protein daw in flight muscle induces autophagosome formation and autophagy gene expression 
(Bai et al., 2013). However, how TGFB-INHB/activin signaling regulates autophagy and how 
this regulation contributes to tissue homeostasis during aging remain largely unknown. Our 
findings suggest that fly INHB/activin-like protein daw promotes cardiac aging through 
inhibition of autophagy and TORC2 signaling. Importantly, fly hearts with reduced daw 
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expression maintain high levels of autophagosome turnover (or autophagic flux) throughout the 
life, whereas the autophagosome turnover is largely blocked in aged hearts of wild-type flies. 
The active autophagosome turnover at old ages is likely responsible for the healthy hearts seen in 
daw knockdown flies. Intriguingly, TORC2 but not TORC1 is required for daw-regulated cardiac 
autophagy. These findings reveal a novel mechanism for age-dependent autophagy regulation 
that is mediated through the interplay between INHB/activin and TORC2. On the other hand, our 
results further suggest that TGFB-INHB/activin acts as a key upstream regulator of TORC2 
signaling. 
The MTOR signaling, in particular, MTORC1, is a well-known autophagy regulator and 
it inhibits autophagosome formation by increasing the phosphorylation of the serine/threonine 
protein kinase Atg1 (ULK1/ULK2 in mammals), the initiator of the autophagy machinery 
(Shibutani & Yoshimori, 2014). Intriguingly, activation of TORC1 does not block the induction 
of autophagosome formation in daw knockdown flies, suggesting that there might be unknown 
TORC1-independent mechanisms involved in daw-regulated autophagy and cardiac aging. 
TORC1-independent autophagy regulation has been observed in several recent studies (Henson 
et al., 2014; Y. Li et al., 2016; Lipinski et al., 2010). A genome-wide screen study identifies an 
important role of class III phosphatidylinositol 3-kinase in autophagy control under normal 
nutritional conditions (Lipinski et al., 2010). The screen also revealed that growth factor 
signaling pathways, such as MAPK/ERK and AKT-FOXO3, negatively regulate autophagy by 
inhibiting the class III phosphatidylinositol 3-kinase cascade. Interestingly, we show that 
knockdown of daw leads to elevated Akt1 phosphorylation and increased expression of TORC2 
subunit rictor, suggesting TORC2-AKT signaling may be involved in daw-regulated autophagy 
and cardiac aging. Indeed, mutation of rictor blocks the activation of autophagy in daw 
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knockdown flies. MTORC2 is one of the two MTOR complexes that is insensitive to short-term 
rapamycin treatment, and is involved in glucose homeostasis and actin cytoskeleton 
reorganization (Gaubitz, Prouteau, Kusmider, & Loewith, 2016; Oh & Jacinto, 2011). The direct 
regulatory role of MTORC2 (RICTOR) in autophagy has not been previously established, 
although several studies suggest that mammalian RICTOR may be involved in autophagy 
activation under certain circumstances. For example, RICTOR is required for resveratrol-induced 
autophagy in rat myocardium and H9c2 cardiac myoblast cells (Gurusamy et al., 2010). In rat 
kidney NRK-52E cells, silencing Rictor blocks cisplatin-induced autophagy (Li et al., 2014). Our 
findings align with these studies suggesting that Drosophila rictor is a positive regulator of 
autophagy. However, conflicting findings are reported in other studies showing RICTOR 
negatively regulates autophagosome formation in mouse skeletal muscle (Mammucari et al., 
2007), and LC3-II levels in human senescent endothelial cells (Xiong et al., 2014). Together, our 
results suggest that Drosophila TORC2 (rictor) is a positive regulator of autophagy, which is 
opposite to what TORC1 does. The distinct regulation of autophagy by 2 MTOR complexes may 
explain why MTORC1 and MTORC2 differentially control lifespan. 
The positive regulation of autophagy by rictor identified in the present study suggests that 
activation of TORC2 may be cardioprotective. Indeed, we show that cardiac-specific 
overexpression of rictor slows cardiac aging, similar to daw knockdown. These findings are 
consistent with two recent studies showing that disruption of mammalian RICTOR induces 
cardiac dysfunction (Sciarretta et al., 2015; Shende et al., 2016). Cardiac-specific deletion of 
Rictor in mice induces dilation and decreases fractional shortening by activating MST1 kinase 
and hippo pathway (Sciarretta et al., 2015). Deletion of Rictor decreases lifespan in male mice 
(Lamming et al., 2014), although conflicting results are reported in C. elegans (Robida-Stubbs et 
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al., 2012; Soukas, Kane, Carr, Melo, & Ruvkun, 2009). Interestingly, we show that cardiac-
specific overexpression of rictor prolongs Drosophila lifespan, which is consistent with 
shortened lifespan seen in rictor deletion mice (Lamming et al., 2014). Besides longevity 
regulation, it has been shown that Drosophila mutants of rictor and Sin1 decrease the tolerance 
to heat stress (Jevtov et al., 2015) and overexpression of rictor rescues Pink1 knockdown-
induced mitochondrial aggregation in Drosophila indirect flight muscle (Wu et al., 2013). 
Conversely, overexpression of PINK1 increases AKT phosphorylation in human SH-SY5Y 
neuroblastoma cells (Murata et al., 2011). The rictor-Pink1 interaction suggests that rictor could 
be a potential positive regulator for mitophagy, a key process for the mitochondria quality 
control during aging. Interestingly, we found that p-Akt1 exhibits a puncta pattern in fly hearts. 
We speculate that the p-Akt1 puncta may be associated with mitochondria and ER 
subcompartment, since it has been shown that MTORC2 (RICTOR) is localized at the 
mitochondria-associated ER membrane (Betz et al., 2013). Future work is needed to examine 
whether and how TORC2 (rictor) regulates mitophagy activity to maintain mitochondrial quality 
in the heart.    
Different from TORC2, TORC1 is known to promote age-dependent increases in cardiac 
dysfunction in Drosophila (Luong et al., 2006; Wessells et al., 2009). Cardiac-specific 
overexpression of TORC1 increases stress-induced heart failure, whereas overexpression of Tsc1 
and Tsc2 prevents the age-related increase of stress-induced heart failure (Wessells et al., 2009). 
Interestingly, we show that activation of TORC1 produced unique cardiac changes that are 
different from aging fly hearts. Cardiac-specific activation of TORC1 via knockdown of Tsc1 
induced heart rate and decreased heart period, which is similar to cardiac dysfunction caused by 
high-fat-diet feeding (Birse et al., 2010). A recent study found that MTORC1 activity does not 
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increase with age in most tissues of wild-type mice, arguing that the assumption about increased 
MTOR signaling driving age-related pathology may be overly simplified (Baar, Carbajal, Ong, 
& Lamming, 2016). Intriguingly, cardioprotective effects of MTOR were previously observed in 
a mouse model with cardiac-specific overexpression of MTOR (MTOR-Tg) (Song et al., 2010). 
The MTOR-Tg mice show attenuated inflammatory response and cardiomyopathy upon left 
ventricular pressure overload induced by transverse aortic constriction. It is unclear whether 
MTOR-Tg affects only MTORC1 or both MTOR complexes. Thus, the distinct role of MTORC1 
and MTORC2 in stress- and aging-induced cardiac dysfunction remains to be further examined.  
During normal aging, the heart undergoes complex phenotypic changes such as 
progressive myocardial remodeling, reduced myocardial contractile capacity, increased left 
ventricular wall thickness and chamber size, prolonged diastole as well as increased arrhythmia 
(Lakatta & Levy, 2003). All of these biological changes can gradually alter cardiac functions and 
confer vulnerability of the heart to various cardiovascular stresses, thus increasing the chance of 
developing cardiovascular disease dramatically. The present study reveals an important role of 
TGFB-INHB/activin signaling pathway in the regulation of autophagy and cardiac aging in 
Drosophila. We also find an intriguing interaction between INHB/activin and TORC2 in the 
regulation of cardiac autophagy, as well as a new role of rictor in cardiac aging and longevity 
control in Drosophila. It remains to be determined how INHB/activin regulates TORC2 (rictor) 
in fly hearts. It is possible that TGFB-INHB/activin signaling regulates rictor through both 
transcriptional activation (e.g., INS-FOXO signaling (C. C. Chen et al., 2010)) and post-
translational modification. Additionally, cardiac-specific daw knockdown and rictor 
overexpression extend fly lifespan, suggesting that longevity can be achieved by maintaining a 
healthy heart. Our findings also suggest that daw itself or other unidentified hormonal factors 
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secreted from cardiomyocytes may play an important role in systemic aging control. Hence, it 
remains to be determined the mechanistic basis for INHB/activin-TORC2-mediated control of 
cardiac aging and longevity, which will eventually help the development of therapeutic 
interventions targeting INHB/activin and TORC2 for the treatment of age-related cardiovascular 
diseases. 
2.5 Material and Methods 
Fly Husbandry and Stocks 
Flies were maintained at 25°C, 60% relative humidity and 12 h light/dark (40% relative 
humidity was used in the experiments from Fig. 1 and 2, which were performed in Bodmer 
laboratory). Adults were reared on agar-based diet with 0.8% cornmeal, 10% sugar, and 2.5% 
yeast (unless otherwise noted). Fly stocks used in the present study are: UAS-daw RNAi 
(Bloomington Drosophila Stock Center [BDSC], 34974, BDSC, 50911, and Vienna Drosophila 
Resource Center [105309]), UAS-daw (dawOE, Gift from Michael O’Connor, University of 
Minnesota Twin Cities), UAS-Smox RNAi (BDSC, 26756), UAS-babo RNAi (BDSC, 25933, 
40866), UAS-baboAct/baboQ302D (Brummel et al., 1999), UAS-Tsc1 RNAi (BDSC, 52931, 54034), 
UAS-REPTOR RNAi (BDSC, 25983), UAS-Rheb (BDSC, 9688), UAS-Atg1 RNAi (BDSC, 
26731), UAS-rictor RNAi (BDSC, 36699), daw[11] (Serpe & O'Connor, 2006), Tsc1[12] (Gao & 
Pan, 2001), rictor[42] (G. Lee & Chung, 2007) , Sin1[e03756] (BDSC, 18188), UAS-rictor(Jevtov et 
al., 2015), UAS-HA-rictor(Jevtov et al., 2015), UAS-Akt1 RNAi (BDSC, 31701), Hand/Hand4.2-
gal4 (Han & Olson, 2005), and tinc/tinc∆4-gal4 (Lo & Frasch, 2001), Ugt36A1/Dot-gal4 
(Zhang, Zhao, & Han, 2013), Hand-GS-gal4 (Monnier et al., 2012), UAS-mCherry-Atg8a 
(BDSC, 37750), Atg8a∆4 (Pircs et al., 2012), UAS-GFP.nls (BDSC, 4775), fln/IFM-gal4, da-GS-
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gal4 (Tricoire et al., 2009), UAS-mCherry-GFP-Atg8a (Gift from Gábor Juhász, Eotvos Lorand 
University, r4-gal4 (Gift from Marc Tatar, Brown University). 
UAS-daw RNAi (BDSC, 34974) and UAS-babo RNAi (BDSC, 25933) were backcrossed 
into ywR background for 5~7 generations, and ywR flies were used as control or wild-type (WT) 
flies in most of the experiments. For other UAS-RNAi lines that were not backcrossed to ywR, 
following genotypes were used as control: y1 sc* v1; P[VALIUM20-mCherry]attP2 (BDSC, 
35785), y1 v1; P[CaryP]attP2 (BDSC, 36303), or y1 v1; P[CaryP]attP40 (BDSC, 36304). 
Female flies were used in all experiments. RU486 (Mifepristone; Cayman Chemical, 84371-65-
3) were used to activate Hand-GS-Gal4 at a final concentration of 200 µM mixed in food. 
Mosaic Analysis 
Two FLPout lines were used: 1). hs-flp; endogenous P-3x mCherry-Atg8a, UAS-
GFP/Cyo; Act>CD2>Gal4,UAS-Dcr-2/TM6) (kindly provided by Gábor Juhász, Eotvos Lorand 
University). 2). yw, hs-flp, UAS-CD8::GFP; Act>y+>Gal4,UAS-GFP.nls;UAS-Dcr-
2/SM6::TM6B (kindly provided by Jun-yuan Ji, Texas A&M University, originally generated by 
Bruce Edgar, University of Utah). To generate clones, freshly laid eggs (within 4-6 h) were 
heated in a 37°C water bath for 45 min. Early L3 larvae (84 h after egg laying) were used in the 
experiments. 
Fly Heartbeat Analysis 
To measure cardiac function parameters, semi-intact Drosophila adult fly hearts were 
prepared according to previously described protocols (Fink et al., 2009). High-speed 3000 
frames movies were taken at a rate of 100 frames per second using a Hamamatsu ORCA-
Flash4.0 digital CMOS camera (Hamamatsu Photonics) on an Olympus BX51WI microscope 
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with a 10X water immersion lens. Hamamatsu EM-CCD 9300 camera was used in the 
experiments from Fig. 1 and 2, which were performed in Bodmer laboratory. The live images 
that contain heart tub within abdominal A3 segment were processed using HCI imaging software 
(Hamamatsu Photonics). M-modes and cardiac parameters were generated using SOHA, a 
MATLAB-based image application as described previously (Fink et al., 2009). The M-mode 
provides a snapshot of the movement of heart wall over time. Cardiac parameters were 
calculated as below: Diastolic interval (DI) is the duration for each heart relaxation phase 
(diastole). Heart period (HP) is the pause time between the two consecutive diastoles (HP is the 
reciprocal of heart rate, HR). Systolic interval (SI) was calculated as the HP minus the DI. 
Arrhythmia index (AI) is the standard deviation of all HP in each fly normalized to the median 
HP. Cardiac output was calculated using following equation: (π r[d]2 - π r[s]2 ) x HR. r(d) is the 
radius of the heart tube at diastolic phase, while r(s) is the radius of the heart tube at systolic 
phase. Fractional shortening was calculated as (diastolic diameters - systolic diameters) / 
diastolic diameters. 
Quantitative RT-PCR 
RNA extraction and cDNA synthesis were performed using a Cells-to-CT kit (Thermo 
Fisher Scientific, 44-029-54) from ~15 dissected adult hearts. QRT-PCR was performed with a 
Quantstudio 3 Real-Time PCR System (Thermo Fisher Scientific). mRNA abundance of each 
gene was normalized to the expression of RpL32 (Ribosomal protein L32) by the method of 
comparative CT. Primer sequences are listed in Table S1. 
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Antibodies and Immunostaining 
Since commercial antibodies for Drosophila Atg8a show non-specific staining in 
immunostaining of fly tissues (data not shown), we used a human GABARAP (E1J4E) antibody 
(1:300) (Cell Signaling Technology [CST], 13733) to stain and detect endogenous Drosophila 
Atg8a. The epitope used to generate GABARAP antibody has identical amino acid sequences to 
Drosophila Atg8a protein (personal communication with Cell Signaling Technology and see 
sequence alignment in Fig. S2A). This antibody has been previously used in several Drosophila 
autophagy studies (Barekat et al., 2016; Ratliff, Barekat, et al., 2016; Ratliff, Kotzebue, et al., 
2016), and verified by Kim et al. (Kim et al., 2015). We further verified the specificity of the 
GABARAP antibody using an Atg8a loss-of-function mutant Atg8a∆4 (Fig. S2B-S2D). Other 
antibodies used for immunostaining are list below: ref(2)P (1:1000) (previously generated by the 
Nezis laboratory) (Nezis et al., 2008), p-Smox/SMAD2 antibody (1:500; CST, 3108), p-
EIF4EBP1 (1:300; CST, 2855), p-AKT1 (Ser473, 1:300; CST, 4060), Alexa Fluor 488-
conjugated phalloidin (or Alexa Fluor 594) for F-actin staining (Thermo Fisher Scientific, 
A12379, A12381). All fluorescence-conjugated secondary antibodies were from Jackson 
ImmunoResearch (Alexa Fluor 488, 711-545-152; Alexa Fluor 594, 711-585-152). 
For immunostaining, adult female flies were collected and dissected in PBS (Fisher 
Scientific, AAJ61196AP). Hearts were fixed in 4% paraformaldehyde for 15 min at room 
temperature (RT). After washing in PBS with 0.1% Triton X-100 (Fisher Scientific, BP151-100) 
(PBST), the fixed hearted were blocked in 5% normal goat serum (NGS; Jackson 
ImmunoResearch, 005-000-121) diluted in PBST for 1 h at RT. Hearts were then washed with 
PBST and incubated overnight at 4°C with primary antibodies diluted in 5% NGS. After washing 
with PBST, the samples were incubated for 2 h at RT with appropriate fluorescence-conjugated 
secondary antibodies. Hearts were mounted in ProLong Gold anti-fade reagent (Thermo Fisher 
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Scientific, P36930) before being imaged using an epifluorescence-equipped Olympus BX51WI 
microscope.  
Imaging Analysis and Quantification. 
For imaging analysis and quantification, fluorescence images were first processed using 
the deconvolution module in Olympus cellSens Dimensions software, and then the number of 
puncta or fluorescent area/intensity in a selected region of interest (ROI, ~707 µm2) surrounding 
cardiomyocyte nuclei were measured with the “Measure and Count” module in Olympus 
cellSens software. To quantify autophagosome in fat body, the number of puncta per cell was 
measured. The imaging quantifications were done single- or double-blind.  
LysoTracker and Magic Red staining 
Acidic organelles (including autolysosome) were monitored by staining tissue with 100 
nM LysoTracker Red DND-99 (Thermo Fisher Scientific, L7528) for 5 min at room temperature. 
Lysosomal CtsB1 (cathepsin B1) activities were monitored using Magic Red Cathepsin-B Assay 
kit (ImmunoChemistry Technologies, 938) following the manufacturer’s manual. Nuclei were 
stained with either DAPI or Hoechst 33342 (1 µg/ml) (ImmunoChemistry Technologies, 938). 
Western Blotting for Atg8a Lipidation and Akt1 Phosphorylation 
Antibodies for western blot included: ACTB (actin beta) antibody (1:2000) (CST, 4967), 
GABARAP (E1J4E) antibody (1:2000) (CST, 13733), Drosophila p-Akt1 (Ser505) (1:1000) 
(CST, 4054), AKT1 (Pan) (1:2000) (CST, 4691), and HRP-conjugated secondary antibodies 
(Jackson ImmunoResearch, 711-035-152). For Atg8a lipidation, flies were first transferred to 
centrifuge tubes containing 1x laemmli buffer (Bio-Rad Laboratories, 1610737) (10 µl buffer for 
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each milligram of fly), and heated at 100°C for 3 min. The samples were then homogenized and 
heated again at 100°C for 3 min. After the centrifuge at 14000 x g for 5 min, supernatants were 
collected and loaded onto Mini-PROTEAN precast gels (Bio-Rad Laboratories, 456-1095). 
Following incubation with primary and secondary antibodies, the blots were visualized with 
Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific, PI34577). For Akt1 
phosphorylation, RIPA lysis buffer (Thermo Fisher Scientific, PI36978) was used to extract 
protein samples. 
Bafilomycin A1 and Chloroquine Treatment 
For bafilomycin A1 treatment, semi-intact hearts were incubated with 100 nM of 
bafilomycin A1 (Fisher Scientific, AAJ61835MCR) in artificial hemolymph (buffer receipt in 
(Fink et al., 2009)) for 2 h at room temperature prior to the appropriate immunostaining. DMSO 
was used as a control.  
For chloroquine treatments, 100 µl of 20 mM chloroquine diphosphate salt, CQ (Fisher 
Scientific, ICN19391925) was added onto the fly food. Flies were fed with chloroquine for at 
least 24 h prior to the cardiac analysis or the western blots. To test the toxicity of CQ treatment, 
we performed a survival analysis by feeding ywR flies with 20 mM CQ and observed the 
mortality within a period of within two weeks (about 100 flies per treatment). Flies were 
transferred to fresh CQ food every day and fly mortality was recorded daily. 
Demography and survival analysis 
Newly enclosed female flies were allowed to mate for two days, then separated from 
males and assigned to replicate one-liter demography cages at a density of 100-125 flies per 
cage. Three independent cages were set-up per genotype. Food was changed every 2 d, at which 
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time dead flies were removed from the cage and counted. Survival analysis was conducted with 
JMP statistical software (SAS Institute), and data from replicate cages were combined. Mortality 
distributions were compared by Log-rank test. 
Statistical Analysis 
GraphPad Prism (GraphPad Software) was used for statistical analysis. To compare the 
mean value of treatment groups versus that of control, either student t-test or one-way ANOVA 
was performed using Tukey multiple comparison. The effects of mutants during aging were 
analyzed by two-way ANOVA, including Tukey multiple comparisons test. In SOHA analysis, 
the outliers were identified using Robust regression and Outlier removal (ROUT) method 
(Q=1%) prior to the data analysis. 
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2.9 Figure and Table Legends 
Figure 1. Heart-specific knockdown of daw slows cardiac aging. (A) QRT-PCR analysis 
of daw expression in young and old fly hearts. N = 3. Student t-test (** p < 0.01). (B) 
Representative M-mode traces (8 s) showing age-dependent movement of heart wall in control 
and heart-specific daw knockdown flies (Hand-gal4> UAS-dawRNAi ). (C-F) Age-related changes 
in arrhythmia index, diastolic intervals, heart period, and cardiac output in control (Ctrl) and 
cardiac-specific daw knockdown flies (dawRNAi ). Flies were cultured at 40% relative 
humidity. Hand-gal4 driver was used to knockdown gene expression specifically in cardiac 
tissues (cardiomyocytes and pericardial cells). Results from three independent UAS-dawRNAi lines 
are shown (RNAi #1: BDSC, 34974, RNAi #2: Vienna Drosophila Resource Center, 105309, 
RNAi #3: BDSC, 50911). N = 7 ~ 20. Two-way ANOVA followed by Tukey multiple 
comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant). The interaction 
between genotype and age is statistically significant for heart period (p = 0.0041) and diastolic 
interval (p = 0.0243). (G-I) Age-dependent changes in cardiac arrhythmia between control 
and daw knockdown using various tissue drivers, Hand-gal4 (cardiomyocytes and pericardial 
cells), tinc-gal4 (cardiomyocytes), and Dot-gal4 (pericardial cells). N = 25 ~ 31. Student t-test (* 
p < 0.05, ** p < 0.01, *** p < 0.001). (J) Age-dependent changes in diastolic intervals between 
control and daw knockdown in pericardial cells (Dot-gal4). N = 13 ~ 26. Student t-test (* p 
< 0.05, ** p < 0.01, *** p < 0.001). (K) Immunostaining of p-Smox in fly hearts at young 
(2 weeks) and old ages (6 weeks). Arrows indicate cardiomyocyte nuclei and positive p-Smox 
staining. Scale bar: 20 μm. Quantification shown on the right. N = 8. Student t-test (* p < 0.05). 
92 
 
Data are represented as mean ± SEM in all figures. (L) Age-dependent changes in arrhythmia 
index, diastolic intervals, heart period between control and Smox knockdown (tinc-gal4). N 
= 11 ~ 31. Student t-test (* p < 0.05). 
cardiac aging. (A-C) Age-dependent changes in cardiac arrhythmia, diastolic intervals, 
and heart period in control (Ctrl) and cardiomyocyte-specific babo knockdown flies (babo RNAi). 
Flies were cultured at 40% relative humidity. tinc-gal4 driver was used. Results from two 
independent UAS-baboRNAi lines are shown (RNAi #1: BDSC, 25933, RNAi #2: BDSC, 40866). 
N=15~30. One-way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (D-F) 
Changes in cardiac arrhythmia, diastolic intervals, and heart period in fly hearts expressing 
constitutively activated babo (baboAct). GeneSwitch heart driver Hand-GS-gal4 was used to 
induce adult-onset babo activation. RU: RU486 (Mifepristone). Flies were cultured at 40% 
relative humidity. N=6~9. One-way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not 
significant). 
Figure 3. daw negatively regulates autophagy in fly hearts. (A) Representative images of 
LysoTracker staining of young adult fat body between wild-type (WT) and heterozygous 
daw[11]/+ mutants. Scale bar: 20 μm. Quantification shown on the right. N=5. Student t-test (*** 
p<0.001). (B) Western blot analysis on Atg8a lipidation between WT and daw[11]/+ mutants. 
GABARAP antibodies were used to detect Atg8a. The lower band represents lipidated Atg8a 
(Atg8a-II), and the upper band represents non-lipidated Atg8a (Atg8a-I). Abdominal fly carcass 
is incubated with 5 μM of BafA1 prior to western blots. ACTB (actin beta) is used as the loading 
control. Quantification of band intensity shown on the right. N=3. Student t-test (*** p<0.001). 
(C) Representative images of mosaic analysis on autophagosome staining in larval fat body. Fat 
body clones were generated by crossing dawRNAi and baboRNAi lines into a FLPout line carrying 
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mCherry-Atg8a reporter (hs-flp; endogenous P-3xmCherry-Atg8a, UAS-GFP/Cyo; 
Act>CD2>Gal4,UAS-Dcr-2). RNAi Clones are GFP-positive cells (dashed lines). Scale bar: 20 
μm. Quantification of autophagosome puncta shown on the right. N=5. Student t-test (** 
p<0.01). (D) Representative images of fly hearts expressing autophagosome reporter mCherry-
Atg8a at both young and old ages. Arrows indicate cardiomyocyte nuclei and surrounding 
autophagosomes. Abdominal segments A2-A3 are shown. Heart tube is located between two 
yellow dashed lines. (E-G) Representative images of mCherry-Atg8a reporter surrounding 
cardiomyocyte nuclei in control, dawRNAi, and baboAct flies with or without BafA1 treatment. 
Semi-intact hearts were incubated with 100 nM of bafilomycin A1 (BafA1) for 2 h prior to 
immunostaining. Scale bar: 10 μm. (H) Quantification of age-dependent changes in autophagic 
flux in control, dawRNAi, and baboAct fly hearts. tinc-gal4 was used to drive the expression of 
mCherry-Atg8a reporter and gene knockdown. N=5~7. One-way ANOVA (*** p<0.001, ** 
p<0.01, * p<0.05, ns = not significant). (I) Quantification of age-dependent changes in 
autophagic flux in control and dawRNAi fly hearts. Hand -gal4 was used to drive the expression of 
mCherry-Atg8a reporter and daw knockdown. N=5~7. One-way ANOVA (*** p<0.001, ** 
p<0.01, * p<0.05, ns = not significant). (J) Quantification of BafA1-induced mCherry-Atg8a-
positive puncta between control and dawRNAi. The data represent the differences in the number of 
puncta between BafA1 and DMSO treatments. 
Figure 4. Inhibition of autophagy, but not activation of TORC1, blocks daw knockdown-
mediated cardioprotection. (A) Cardiac arrhythmia of chloroquine-treated (20 mM, 24 h) 6-
week-old control and daw knockdown flies (Hand-gal4 used). N=14~38. One-way ANOVA 
(*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (B) Cardiac diastolic intervals and 
arrhythmia in heart-specific knockdown of Atg1 at young and old ages (Hand-gal4 used). 
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N=16~19. One-way ANOVA (*** p<0.001, * p<0.05). (C) Age-dependent changes in cardiac 
arrhythmia in control, dawRNAi, and dawRNAi; Atg1RNAi flies (tinc-gal4 used). N=16~35. One-way 
ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (D-E) Cardiac arrhythmia and 
diastolic intervals of Tsc1 knockdown flies (tinc-gal4 used). Two independent Tsc1 RNAi lines 
were used (RNAi-1: BDSC, 52931, RNAi-2: BDSC, 54034). N=16~18. One-way ANOVA (*** 
p<0.001, ** p<0.01, * p<0.05, ns = not significant). (F) Age-dependent changes in cardiac 
arrhythmia in control, dawRNAi, and dawRNAi; Tsc1RNAi flies (tinc-gal4 used). N=7~30. One-way 
ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (G) Representative images of 
LysoTracker staining in adult fat body of WT, daw[11]/+, Tsc1[12]/+ and double mutants 
daw[11]/+; Tsc1[12]/+. Scale bar: 10 μm. Quantification shown on the right. N=5. One-way 
ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). 
Figure 5. daw genetically interacts with TORC2 (rictor) to control autophagy. (A) 
Representative images of p-Akt1 staining in cardiomyocytes of control and daw knockdown flies 
(Hand-gal4). Scale bar: 10 μm. Quantification shown on the right. N=5. Student t-test (* 
p<0.05). (B) Representative images of p-Akt1 staining in cardiomyocytes of control and babo-
activated flies (Hand-gal4). Scale bar: 10 μm. Quantification shown on the right. N=5. Student t-
test (*** p<0.001). (C) Western blot analysis on Akt1 phosphorylation of the hearts dissected 
from control, daw knockdown and babo-activated flies (Hand-gal4). Quantification of band 
intensity shown on the right. N=3. Student t-test. (D) Representative images of p-Akt1 staining 
in cardiomyocytes of control and rictor overexpression (Hand-gal4). Two independent rictor 
overexpression used (#1: UAS-rictor, #2: UAS-HA-rictor (Jevtov et al., 2015)). Scale bar: 10 μm. 
Quantification shown on the right. N=5. One-way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, 
ns = not significant). (E) QRT-PCR analysis of rictor expression in fly hearts with daw and babo 
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knockdown (Hand-gal4). N=3. Student t-test (* p<0.05). (F) Representative images of 
LysoTracker staining in adult fat body of WT, daw[11]/+, rictor[42]/+ and double mutants 
rictor[42]/+; daw[11]/+. Scale bar: 20 μm. Quantification shown on the right. N=5. One-way 
ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (G) Representative images of 
Magic Red staining in adult fat body of WT, daw[11]/+, rictor[42]/+ and double mutants 
rictor[42]/+; daw[11]/+. Scale bar: 20 μm. Quantification shown on the right. N=5. One-way 
ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (H) Representative images of 
GABARAP immunostaining in cardiomyocytes of BafA1-treated control, dawRNAi alone, 
dawRNAi; rictorRNAi, and dawRNAi; Akt1RNAi flies. Scale bar: 20 μm. Quantification shown on the 
right. N=15. Student t-test (*** p<0.001). (I) Representative images of mosaic analysis of 
LysoTracker staining in larval fat body. Fat body clones were generated by crossing rictor 
overexpression lines into a FLPout line (yw, hs-flp, UAS-CD8::GFP; Act>y+>Gal4,UAS-
GFP.nls;UAS-Dcr-2). Clones with rictor overexpression are GFP-positive cells (dashed lines). 
Scale bar: 20 μm. (J) Representative images of mosaic analysis of autophagosome staining in 
larval fat body. Fat body clones were generated by crossing rictor overexpression lines into a 
FLPout line carrying mCherry-Atg8a reporter (hs-flp; endogenous P-3x mCherry-Atg8a, UAS-
GFP/Cyo; Act>CD2>Gal4,UAS-Dcr-2). Clones with rictor overexpression are GFP-positive 
cells (dashed lines). Scale bar: 20 μm. 
Figure 6. Heart-specific overexpression of rictor preserved cardiac function during 
aging. (A) Representative images of p-Akt1 staining in young and old cardiomyocytes of wild-
type flies. Scale bar: 10 μm. Quantification shown on the right. N=12. Student t-test (** p<0.01). 
(B) Representative images of autophagic flux in control and rictor overexpressing 
cardiomyocytes at old ages (Hand-gal4). Scale bar: 10 μm. Quantification shown on the right. 
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N=15. One-way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (C-D) 
Diastolic intervals and arrhythmia index in flies with heart-specific overexpression of rictor 
(Hand-gal4). N=19~26. One-way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not 
significant). (E) Cardiac arrhythmia index in flies with heart-specific knockdown of rictor. 
N=24. One-way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (F) Cardiac 
arrhythmia index in flies with heart-specific knockdown of daw alone or daw; rictor double 
knockdown. N=15~30. Student t-test (*** p<0.001, * p<0.05, ns = not significant). (G-I) 
Diastolic intervals, arrhythmia index, and heart period in flies with heart-specific expression of 
baboAct, or baboAct; rictorOE (Hand-gal4). N=11~27. One-way ANOVA (*** p<0.001, ** 
p<0.01, * p<0.05, ns = not significant). (J) Proposed model: INHB/activin-mediated inhibition of 
MTORC2 as a novel mechanism for age-dependent regulation of autophagy and cardiac health. 
Figure 7. Cardiac-specific knockdown of daw and overexpression of rictor prolong 
lifespan. (A-B) Survival analysis of cardiac-specific (tinc-gal4 and Hand-gal4) knockdown of 
daw. Two control lines used (yw and mCherry RNAi) were performed. Log-Rank test, p<0.0001. 
(C) Survival analysis of heart-specific (Hand-gal4) overexpression of rictor. Log-Rank test, 
p=0.0005. (D) Lifespan table to show sample size, mean and median lifespan of the survival 
analysis. 
Supporting Information 
Figure S1. Validation of cardiac drivers and RNAi lines. (A) Representative images of 
two cardiac driver lines crossing into UAS-GFP.nls. Heart tube is located between two dashed 
lines. PC: pericardial cells. Scale bar: 40 μm. (B) Quantification of GFP intensity in Panel S1A. 
N=4. Student t-test (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (C-D) QRT-PCR 
analysis on the knockdown efficiency of three daw RNAi lines (Da-GS-gal4 and IFM-gal4 
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used). N=3. Student t-test (* p<0.05). (E-H) Age-related changes in systolic intervals, fractional 
shortening, diastolic diameter, and systolic diameter in control (Ctrl) and cardiac-specific daw 
knockdown flies (dawRNAi) (Hand-gal4 used). N=7~20. One-way ANOVA followed by Tukey 
multiple comparisons test (* p<0.05, ** p<0.01, *** p<0.001, ns = not significant). (I-J) Age-
related changes in arrhythmia index of three control fly lines. N=10~34. Student t-test (* p<0.05, 
** p<0.01, *** p<0.001, ns = not significant). (K) Age-related changes in diastolic interval in 
control (Ctrl) and cardiac-specific daw overexpression flies (dawOE) (Hand-gal4 used). N=7~20. 
Student t-test (* p<0.05). (L) Age-related changes in cardiac output in control (Ctrl) and cardiac-
specific babo knockdown flies (baboRNAi) (tinc-gal4 used). N=15~30. One-way ANOVA 
followed by Tukey multiple comparisons test (* p<0.05, ** p<0.01, *** p<0.001, ns = not 
significant). (M-N) Age-related changes in diastolic diameter, and systolic diameter in control 
(Ctrl) and cardiac-specific babo knockdown flies (baboRNAi) (tinc-gal4 used). N=15~30. Student 
t-test (ns = not significant). 
Figure S2. Validation of GABARAP antibody. (A) Multiple sequence alignment 
between Drosophila Atg8a and human GABARAP using ClustalW 
(https://www.genome.jp/tools-bin/clustalw). The red box indicates the predicted epitope 
sequences used in producing GABARAP antibody. (B) Representative images of GABARAP 
immunostaining in fly hearts of WT and Atg8a∆4 mutants. Heart tube is located between 2 white 
dashed lines. The panels on the right are the zoomed-in images. Scale bar: 20 μm. (C) 
Representative images of GABARAP immunostaining in adult fat body of WT and Atg8a∆4 
mutants. The panels on the right are the zoomed-in images. Scale bar: 20 μm. (D) Western blots 
testing GABARAP antibody using Atg8a∆4 mutants. 
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Figure S3. daw inhibits autophagy flux in the heart. (A) Representative images 
corresponding to anti-HsGABARAP immunostaining in fly hearts of WT and daw[11]/+ mutants 
treated with or without BafA1. Heart tube is located between 2 white dashed lines. Scale bar: 20 
μm. (B) Quantification of Panel S3A. N=5. One-way ANOVA (*** p<0.001, ** p<0.01, * 
p<0.05, ns = not significant). (C) Quantification of BafA1-induced puncta between WT and 
daw[11]/+ mutants. 
Figure S4. Autophagy flux decreases in aging hearts. (A) Representative images of 
GABARAP immunostaining in young and old fly hearts of WT treated with or without BafA1. 
Heart tube is located between 2 white dashed lines. Scale bar: 20 μm. The panels on the right are 
the zoomed-in images (Scale bar: 10 μm). (B) Quantification of Panel S4A. N=15. One-way 
ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (C) Representative images 
showing mCherry-GFP-Atg8a tandem reporter in wild-type fly hearts treated with or without 
BafA1. Heart tube is located between two dashed lines. Scale bar: 20 μm. (D) Representative 
images showing mCherry-GFP-Atg8a tandem reporter in wild-type 3rd instar larval fat body 
treated with or without BafA1. Scale bar: 20 μm. 
Figure S5. Aging increases the accumulation of ref(2)P in the heart. (A-B) 
Representative images of ref(2)P in young and old hearts. Scale bar: 10 μm. (C) Representative 
images of ref(2)P in the heart of Atg8a∆4 mutants. Scale bar: 10 μm. (D) Survival curve of CQ-
treated flies. Wild-type flies (ywR) were fed on 20 mM CQ (about 100 flies per treatment). (E) 
QRT-PCR analysis on the knockdown efficiency of dawRNAi, or dawRNAi;Atg1RNAi combine lines. 
N=3. Student t-test. 
Figure S6. Activation of TORC1 alters heart period, but not arrhythmia. (A) Schematic 
diagram for the PI3K-AKT-TOR signaling pathway. (B) Representative images of p-Thor 
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staining in cardiomyocytes of daw and Tsc1 RNAi flies (tinc-gal4 used). Scale bar: 10 μm. 
Quantification shown on the right. N=6. Student t-test (** p<0.01). (C) QRT-PCR analysis of the 
knockdown efficiency of Tsc1 RNAi. Student t-test (*** p<0.001). (D-F) Heart period, diastolic 
intervals, and arrhythmia in control (Ctrl) and cardiomyocyte-specific Tsc1 knockdown flies 
(tinc-gal4). N=14~18. One-way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not 
significant). (G-I) Heart period, diastolic intervals, and arrhythmia in control (Ctrl) and 
cardiomyocyte-specific REPTOR knockdown flies (tinc-gal4). N=13~28. One-way ANOVA 
(*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (J-L) Heart period, diastolic intervals, 
and arrhythmia in control (Ctrl) and flies overexpressing Rheb (tinc-gal4). N=21~31. One-way 
ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant).  
Figure S7. Autophagy regulation by MTORC2. (A) Representative images of 
LysoTracker staining in adult fat body of WT, daw[11]/+, Sin1[e03756]/+ and double mutant 
Sin1[e03756]/+; daw[11]/+. Scale bar: 20 μm. (B) Image quantification of Panel S7A. N=5. One-
way ANOVA (*** p<0.001, ** p<0.01, * p<0.05, ns = not significant). (C) Representative 
images of LysoTracker staining in fed and starved WT, Tsc1[12]/+ mutants, and rictor[42]/+ 
mutants. Scale bar: 20 μm. Image quantification shown on the right. N=5~8. Student t-test (** 
p<0.01, ns = not significant). (D) Representative images of mosaic analysis on LysoTracker 
staining in larval fat body of baboAct flies upon starvation. Larval fat body clones were generated 
using a FLPout line (yw, hs-flp, UAS-CD8::GFP; Act>y+>Gal4,UAS-GFP.nls;UAS-Dcr2). 
Clones with baboAct expression are GFP-positive cells (dashed lines). Scale bar: 20 μm. 
Figure S8. Original western blot images. (A) Original western blot of Fig. 3b (anti-
GABARAP). (B) Original western blot of Fig. 3b (anti-ACTB). (C) Original western blot of Fig. 
5c (anti-p-AKT1). (D Original western blot of Fig. 5c (anti-AKT1). 
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Table S1. Primer list (separate file) 
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Figure 4. Inhibition of autophagy, but not activation of TORC1, blocks daw knockdown-
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Table S1. Primer list 
Primer name Primer sequence (5’-3’) Symbol FlyBase ID 
RpL32-f AAGAAGCGCACCAAGCACTTCATC RpL32 FBgn0002626 
RpL32-r TCTGTTGTCGATACCCTTGGGCTT RpL32 FBgn0002626 
daw-f TGAGCCACCTCATCCAAATCACCT daw FBgn0031461 
daw-r TCGATCACGATGAATGGCCGGTAA daw FBgn0031461 
rictor-f CCCAACTGGCTAGCGTTTAT rictor FBgn0031006 
rictor-r GGCCTTTGCTTTCGTTTGAG rictor FBgn0031006 
Tsc1-f TCGATTGGCTGGCGATAACA Tsc1 FBgn0026317 
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3.1 Abstract 
Investigating the deleterious effects of a high-fat diet (HFD) and its genetic regulators is 
vital to understand the mechanisms contributing to obesity-induced cardiovascular diseases. 
MTOR pathway has been previously shown to regulate high-fat diet (HFD)-induced obesity and 
heart dysfunction in Drosophila. Our studies suggest that MTORC2 could protect the heart under 
HFD feeding. Upon five days of HFD feeding, the heart exhibits contractile dysfunction and 
altered mitochondrial physiology, including mitochondrial fragmentation, loss of mitochondrial 
membrane potential, and mitochondrial calcium overload. We also observed that the activity of 
MTORC2 in heart is reduced upon five days of HFD feeding. In line with this finding, the flies 
with cardiac-specific MTORC2 reduction by rictor knockdown mimic HFD-induced cardiac and 
mitochondrial dysfunction even on a normal diet. Conversely, cardiac-specific activation of 
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MTORC2 by overexpressing rictor rescued the above HFD-induced cardiac and mitochondrial 
dysfunction, suggesting that MTORC2 provides cardioprotection against HFD.  
3.2 Introduction 
Obesity has grown to pandemic levels with nearly three folds increases since 1975 
(Blüher, 2019). Increasing evidence suggests that obesity and its associated metabolic disorders 
caused by excessive fat intake increase the risk of developing secondary diseases such as type-2 
diabetes and cardiovascular diseases (Ryan Tyge Birse & Bodmer, 2011). Obese people and 
type-2 diabetic patients exhibit several cardiac dysfunctions including ventricular remodeling, 
diastolic/systolic dysfunction, decreased fractional shortening, and prolonged QT intervals (Ryan 
T Birse et al., 2010; Ryan Tyge Birse & Bodmer, 2011; Christoffersen et al., 2003; Zhang & 
Ren, 2011). Therefore, investigating the deleterious effects of a high-fat diet (HFD) and its 
genetic regulators is vital to understand the mechanisms contributing to obesity-induced 
cardiovascular diseases.  
Cardiomyocytes require a constant supply of energy in the form of adenosine 
triphosphate (ATP) to support its contractile function. Under normal condition, most ATP in 
cardiomyocytes is generated through β-oxidation of free fatty acids (FFAs). However, a well-
regulated balance between the metabolism of fatty acids and carbohydrates is also essential to 
maintain normal cardiac function (Lopaschuk, Folmes, & Stanley, 2007). Therefore, the heart 
has high flexibility choosing its metabolic substrates depending on the fuel availability 
(Taegtmeyer, Golfman, Sharma, Razeghi, & van Arsdall, 2004; Wall & Lopaschuk, 1989). 
During the development of obesity via high caloric intake (e.g. HFD), the availability of FFAs is 
increased in the heart, which in turn accelerates fatty acid oxidation. When the level of FFA 
intake in cardiomyocytes is so high, that exceeds the cardiac mitochondrial oxidative capacity, 
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the lipids or their metabolites accumulate within the heart, which eventually leads to cardiac 
steatosis and contractile dysfunction (Lopaschuk et al., 2007). Consistently, several studies have 
also shown that increased cardiomyocyte-specific lipid deposition by manipulating genes 
involved in fatty acid uptake, metabolism, and utilization contributes to cardiac dysfunction 
(Chiu et al., 2005; Haemmerle et al., 2006; Hirano, Ikeda, Zaima, Sakata, & Matsumiya, 2008; 
Hoy et al., 2011; Yagyu et al., 2003). For example, increasing cardiac FFA uptake by 
overexpressing the cardiac-specific lipoprotein lipase (LpL), an enzyme that hydrolyzes 
circulating triglycerides and liberates FFAs, resulted in dilated hearts along with systolic 
dysfunction in mice even under normal diet (Yagyu et al., 2003). Moreover, increased fatty acid 
oxidation in obesity can exert a suppressive effect on carbohydrate oxidation in the heart through 
inhibiting cytosolic glycolysis and mitochondrial pyruvate dehydrogenase, which reduces the 
flexibility of substrate selection and impairs the metabolic balance mentioned above (Lopaschuk 
et al., 2007; Muoio, 2014). Ultimately, a systemic metabolic dysfunction including glucose 
intolerance and insulin resistance occurs, which further leads to the deterioration of cardiac 
function (Ryan Tyge Birse & Bodmer, 2011; Lopaschuk et al., 2007).  
Despite extensive studies on cardiac metabolism in obesity, the underlying mechanisms 
of obesity remain mostly unknown. Mitochondria, as the metabolic hub, also serve an essential 
role in providing energy for the heart. Therefore, mitochondrial dysfunction plays a central role 
in the progression of cardiomyopathy under nutrient overload (Boudina et al., 2007; Lopaschuk 
et al., 2007). Indeed, many studies observed altered mitochondrial physiology under HFD 
treatment, especially in rodents (Table 1). It is noteworthy that mitochondria are highly dynamic 
organelles that are sensitive to subtle cellular changes. Different factors such as HFD 
composition, duration of HFD treatment, time point to start the treatment, and tissue-specific 
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effect can contribute to mitochondrial responses, making this topic challenging to study in 
animal models such as rodents and leads to many conflicting results. For example, several 
studies reported that mitochondrial function was unaffected or even increased after feeding 
(Cormier, Champigny, Simard, St-Coeur, & Pichaud, 2019; Hoeks et al., 2011). Therefore, it is 
necessary to define the precise mitochondrial responses to HFD so that we could better 
understand the mechanisms underlying HFD-induced mitochondrial changes, especially in the 
heart.  
The mechanistic target of rapamycin (MTOR) pathway is a highly conserved nutrient-
sensing pathway that functions through two structurally and functionally distinct complexes, 
MTOR complex 1 (MTORC1) and MTOR complex 2 (MTORC2), to regulate a wide range of 
cellular function including protein synthesis, ribosomal and mitochondrial biogenesis, 
autophagy, and metabolism (Laplante & Sabatini, 2012; Saxton & Sabatini, 2017). Abundant 
evidence suggests that obesity and nutrient overload induce a hyper-activation of MTOR activity 
in multiple tissues, contributing to the development of type-2 diabetes and insulin resistance 
(Mao & Zhang, 2018). Recently, a study in Drosophila showed that MTOR signaling also plays 
a central role in HFD-induced heart dysfunction. Reducing insulin-MTOR pathway activity 
prevents HFD-induced triglyceride levels and cardiac abnormalities (Ryan T Birse et al., 2010). 
Additionally, increasing AMPK/MTOR pathway activity has also been observed in rats fed with 
HFD to mediate vascular dysfunction and remodeling (Ma et al., 2010). However, the above 
studies did not differentiate the effects coming from two MTOR complexes. To our knowledge, 
most of the genetic manipulation that induces MTOR activity is achieved by activating 
MTORC1 activity. Therefore, relatively to MTORC1, the upstream signals and downstream 
substrates of MTORC2 are less known. Recently, growing evidence suggests that MTORC2 
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might also play a role in HFD-induced obesity and insulin resistance via an unknown mechanism 
(Bae et al., 2016; Chellappa et al., 2019; Dadalko, Niswender, & Galli, 2015; Mao & Zhang, 
2018). For example, HFD significantly decreases the protein levels of MTORC2 and pAKT, 
which is opposite to the protein levels of MTORC1 (Bae et al., 2016). Mice with MTORC2 
deficiency display glucose tolerance that is generally observed in HFD treatment (Cybulski, 
Polak, Auwerx, Rüegg, & Hall, 2009). A recent study in neurons suggests that MTORC2 might 
also affect how rewarding high-fat foods are (Dadalko et al., 2015). Interestingly, a recent study 
has shown that MTORC2 localizes to mitochondrial-associated endoplasmic reticulum (ER)-
membranes (MAMs) to regulate mitochondrial physiology (Betz, Stracka, Prescianotto-
baschong, Frieden, & Demaurex, 2013). As its name indicated, MAMs represent a region where 
ER makes contact with mitochondria. MAMs are involved in importing the lipid and calcium 
from the ER to mitochondria and regulating mitochondrial dynamics and metabolism (Rieusset, 
2018). Moreover, this crosstalk between mitochondria and ER is a prerequisite for healthy 
cardiac function (S. Wu & Zou, 2019; Xia et al., 2019). Therefore, it is likely that MTORC2 
might regulate HFD-induced obesity and cardiac dysfunction via mediating mitochondrial 
physiology at MAMs. Collectively, MTORC2 seems to play a different, or even an opposite role 
to MTORC1 in the regulation of HFD-induced obesity, which requires further investigation.  
Drosophila melanogaster has recently emerged as a suitable model to investigate the 
genetic mechanisms underlying HFD-induced obesity and cardiac dysfunction (Bodmer, 1995; 
Colombani et al., 2003; Lee & Park, 2004; Ocorr et al., 2007; Reiter, Potocki, Chien, Gribskov, 
& Bier, 2001). Drosophila fed a HFD exhibit increased triglyceride fat, deregulation of insulin-
MTOR signaling, insulin resistance, oxidative stress, metabolic inflexibility, and cardiac 
dysfunction. A recent study in Drosophila skeletal muscles showed that mitochondrial 
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respiration is also affected by HFD treatment even though measurements on other mitochondrial 
physiology such as mitochondrial morphology and membrane potential are still lacking (Cormier 
et al., 2019). In this study, we used Drosophila as our model to investigate mitochondrial 
responses under HFD, especially in the heart, and the role of MTORC2 in regulating these 
responses. Our results indicated that MTORC2 could provide cardio-protection in response to 
HFD. 
3.2 Results 
To better understand how HFD affects heart function in Drosophila, we first investigate 
the cardiac mitochondrial physiology and cardiac contractile function after feeding a HFD. 
Specifically, we fed Drosophila either a standard diet (SD) or a HFD (SD supplemented with 
20% (w/v) coconut oil) for five days before the measurement. Several studies suggest that HFD 
induces a shift toward mitochondrial fission (Chen, Li, Zhang, Zhu, & Gao, 2018; Jheng et al., 
2012; Leduc-Gaudet et al., 2018). Consistently, we found that the cardiac mitochondria became 
fragmented upon five days HFD treatment, indicated by a significantly increased number of 
smaller mitochondria in the HFD-treated heart (Figure 1A, B). Mitochondrial membrane 
potential (ΔΨm), as an essential component in oxidative phosphorylation, is a crucial indicator of 
mitochondrial activity, especially for cells with high ATP demand, such as cardiomyocytes, 
where ATP turnover has greater control over mitochondrial respiration and mitochondrial 
membrane potential. Therefore, we measured the mitochondrial membrane potential by 
tetramethylrhodamine ethyl ester (TMRE), a cell-permeable and cationic red-orange dye, in 
Drosophila heart fed with a HFD as well. We found that five days of HFD feeding significantly 
decreased ΔΨm in Drosophila heart than SD, suggesting that HFD impairs the cardiac 
mitochondrial respiration (Figure 1C, D). Calcium (Ca2+) plays a critical role in regulating 
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mitochondrial energy production and apoptosis. Besides, mitochondrial Ca2+ uptake has been 
closely linked to the regulation of mitochondrial dynamics and membrane potential. 
Mitochondrial membrane potential also serves as the driving force for Ca2+ uptake into the 
mitochondrial matrix. Thus, we next measured the mitochondrial Ca2+ levels in the HFD heart by 
normalizing mitochondrial-targeted Ca2+ reporter mito-GCaMP5 to mitochondrial mass (DsRed-
mito). Our results indicated that HFD significantly increased the mitochondrial Ca2+ levels in the 
fly heart (Figure 1E, F). Finally, we investigated how does HFD affects heart contractile 
function. In line with a previous study (Ryan T Birse et al., 2010), we also observed cardiac 
dysfunction reminiscent to a restrictive heart under HFD treatment (Cammarato et al., 2008). 
Specifically, HFD slightly reduced diastolic diameter (DD) and significantly diminished diastolic 
interval (DI), and fractional shortening (FS) (Figure 2A-C). Collectively, HFD affects cardiac 
mitochondrial physiology as well as heart function in Drosophila.  
Previous studies suggest that MTORC2 plays a role in HFD-induced obesity and 
MTORC2/rictor deficiency displays HFD-related phenotypes (Bae et al., 2016; Chellappa et al., 
2019; Cybulski et al., 2009; Dadalko et al., 2015; Mao & Zhang, 2018). Similarly, we also 
observed that cardiac-specific rictor knockdown resulted in changes similar to HFD-induced 
alterations of mitochondrial physiology and cardiac contractile patterns. We found that knocking 
down rictor in the heart induced mitochondrial fragmentation, dissipation of mitochondrial 
membrane potential, Ca2+ levels, and adversely affects cardiac function, including reducing DI, 
FS, and DD (Figure 2A-C). Consistently, we also found that the MTORC2/rictor protein level in 
the heart is reduced by five days of HFD treatment (Figure 3A, B). Therefore, reduced 
MTORC2/rictor activity in the heart at least partially takes part in regulating HFD-induced 
alterations in mitochondrial physiology and cardiac function in Drosophila.  
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At last, we verified whether increasing MTORC2/rictor activity in the heart could rescue 
the HFD-induced mitochondrial and cardiac dysfunction. Our results suggested that cardiac-
specific overexpression rictor prevents HFD-induced mitochondrial fragmentation (Figure 4A, 
C), dissipation of mitochondrial membrane potential (Figure 4B, D), and cardiac dysfunction 
(Figure 5A, B). Therefore, we concluded that MTORC2/rictor could provide cardio-protection in 
response to HFD. 
3.3 Discussion 
In this study, we evaluated the mitochondrial physiology and the contractile function in 
Drosophila heart when exposing to a HFD compared to a SD. Our results showed that HFD 
reduces MTORC2/rictor activity and induces mitochondrial fragmentation, dissipation of 
membrane potential, mitochondrial Ca2+ levels, and contractile dysfunction in Drosophila heart. 
Knocking down MTORC2/rictor in heart phenocopied above HFD-induced changes even on a 
SD, while overexpressing MTORC2/rictor in heart abolished above HFD-induced mitochondrial 
and cardiac dysfunction. Our study revealed a novel role of MTORC2/rictor in regulating cardiac 
mitochondrial physiology and HFD-induced cardiac dysfunction.  
Mitochondria are known to change their architecture to meet the bioenergetic needs under 
different nutrient environments. Generally speaking, mitochondria tend to remain fragmented 
under lipid overload or other rich-nutrient environment and elongated under starvation 
conditions (Gao, Cantó, & Houtkooper, 2014; Liesa & Shirihai, 2013). This nutrient-induced 
mitochondrial fission supports “energy wasting” by enhancing uncoupling and basal protein 
conductance, which helps an increase in mitochondrial respiration meanwhile, a decrease in ATP 
synthesis efficiency (Gao et al., 2014; Liesa & Shirihai, 2013). The mechanism by which 
mitochondrial fragmentation enhances uncoupling is not yet understood. One of the possibilities 
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is that fragmentation might represent a change in cristae structures that allows the increased 
nutrient import and prevents mitochondrial ATP synthase dimerization (Frezza et al., 2006; Liesa 
& Shirihai, 2013). Even though mitochondrial fission seems to provide an adaptive response 
initially under a HFD, long-term exposure to nutrient overload such as a HFD still leads to 
increased ROS production, which is the major contributor to insulin resistance and mitochondrial 
dysfunction (Bonnard et al., 2008).  
Mitochondrial membrane potential is highly correlated with the mitochondrial respiration 
rate (Zorova et al., 2018). The effect of nutrient overload on mitochondrial respiration and 
membrane potential remains controversial. Some studies suggest that nutrient excess increases 
mitochondrial respiration and membrane potential (Goehring et al., 2012; Mollica, Iossa, 
Liverini, & Soboll, 1998), whereas others indicate that mitochondrial respiration is impaired by 
nutrient overload (Cormier et al., 2019; Zalewska, Ziembicka, Żendzian-Piotrowska, & 
Maciejczyk, 2019). A recent study in Drosophila skeletal muscles showed that mitochondrial 
respiration increases after two days on a HFD, followed by a significant decrease in 
mitochondrial respiration after four days of a HFD feeding. They demonstrated that the increased 
carbohydrates oxidation might contribute to the initial mitochondrial respiration increase since 
carbohydrates are the main fuel sustaining mitochondrial metabolism in muscles (Zurlo, Larson, 
Bogardus, & Ravussin, 1990). After continuous exposure to a HFD, the metabolic inflexibility 
occurs due to accumulated FFAs and depleted carbohydrates. Ultimately, the impairment of 
mitochondrial respiration ensues (Cormier et al., 2019). This evidence suggests that HFD 
treatment duration is one possible reason for the previous divergent results on mitochondrial 
membrane potential measurement. In addition, different cell types act distinctly to sense nutrients 
and utilize energy. For instance, nutrient utilization and its availability have greater control over 
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mitochondria respiration and membrane potential in nutrient sensors such as beta cells. In 
contrast, ATP turnover significantly influences mitochondrial respiration and membrane 
potential in cells under high ATP demand such as muscle cells (Liesa & Shirihai, 2013). 
Therefore, the HFD-induced dissipation of cardiac mitochondrial membrane potential observed 
in our study is more likely to represent a deleterious condition caused by reduced ATP turnover, 
where the energy to support the contractile function is compromised. Unlike skeletal muscle, 
cardiomyocyte generates mostly ATP via fatty acid oxidation (Lopaschuk et al., 2007), which 
might explain why we did not see an increase in mitochondria membrane potential upon two 
days of HFD feeding.  
Ca2+, a well-known regulator for mitochondrial function, is imported into the 
mitochondria matrix driven by membrane potential (Zorova et al., 2018). Once the Ca2+ enters 
the mitochondrial matrix, it controls the activities of several dehydrogenases in Kreb cycles, 
therefore regulates mitochondrial bioenergetics (Glancy & Balaban, 2012). However, on the 
other hand, under the Ca2+ overload condition, increasing Ca2+ levels within the matrix could 
also promote mitochondrial permeability transition pore (mPTP) opening and dissipate 
mitochondria membrane potential (Wong, Steenbergen, & Murphy, 2012). Beyond 
mitochondrial energy metabolism, mitochondrial Ca2+ also promotes apoptosis under various 
stress conditions (Giorgi et al., 2012). Recently, increasing evidence also suggests crosstalk 
between mitochondrial Ca2+ uptake and mitochondrial fission since both of these processes 
require the proximity between ER and mitochondria (Favaro et al., 2019; J. R. Hom, Gewandter, 
Michael, Sheu, & Yoon, 2007; J. Hom, Yu, Yoon, Porter, & Sheu, 2010). Collectively, 
mitochondrial Ca2+ is involved in a wide range of mitochondrial functions including 
mitochondrial fission and membrane potential. A recent study showed that obesity leads to 
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increased mitochondrial Ca2+ uptake from ER via the MAM connections(Arruda et al., 2014), 
and mitochondrial Ca2+ overload is known to lead to mPTP opening that triggers cardiac 
reperfusion injury (Griffiths & Halestrap, 1995; Murphy & Steenbergen, 2008). Indeed, HFD has 
shown to increase the vulnerability of hearts to ischemic reperfusion (Littlejohns et al., 2014). 
Therefore, the HFD-induced cardiac dysfunction observed in our studies might be due to 
deregulated mitochondrial Ca2+ uptake. Altogether, based on previous studies and our results, we 
speculate that the decreased mitochondrial function observed on five days of a HFD is not a 
regulated adaptive process but instead caused by damaging effects caused by nutrient excess.  
To the best of our knowledge, there is only one study investigated the direct regulation 
between MTORC2 and mitochondria (Betz et al., 2013) despite some of the indirect evidence 
suggesting that MTORC2 is involved in mitochondrial quality control (Aspernig et al., 2019; Z. 
Wu et al., 2013).  In that specific study, they found that MTORC2 localizes to MAM to regulate 
its integrity and inhibits ER calcium release through IP3R. Therefore, testing whether MTORC2 
provides cardioprotection via regulating MAM integrity and Ca2+ flux in response to a HFD 
could be one of the future directions. Additionally, our previous study has shown that MTORC2 
slows cardiac aging through activating autophagy (Chang et al., 2019); it is possible that 
MTORC2 also activates mitophagy to protect the heart from a HFD. In summary, our studies 
revealed a novel role of MTORC2 in the regulation of mitochondria in a HFD heart, study the 
mechanistic link between MTORC2 and mitochondria in the future could provide new insights 
for understanding MTORC2 and obesity-induced cardiovascular diseases. 
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3.4 Materials and Methods 
Fly Husbandry and Stocks 
Flies were maintained at 25°C, 60% relative humidity and 12 h light/dark. Female flies 
(1-2 weeks of age) were fed on a SD (agar-based diet with 0.8% cornmeal, 10% sugar, and 2.5% 
yeast) or a HFD (SD supplemented with 20% w/v coconut oil) for 5 days at constant densities (5 
flies per vial). Fly stocks used in the present study are: UAS-rictor RNAi (BDSC, 31527), 
Hand4.2-gal4 (Han & Olson, 2005), UAS-rictor (Jevtov et al., 2015), UAS-mito-
GCaMP5/DsRed-mito (Gift from Fumiko Kawasaki, Pennsylvania State University). ywR flies 
were used as control or wild-type (WT) flies. 
Fly Heartbeat Analysis 
To measure cardiac function parameters, semi-intact Drosophila adult fly hearts were 
prepared according to previously described protocols (Vogler & Ocorr, 2009). In this study, we 
used the previous published fly heartbeat analysis (Chang et al., 2019). In brief, flies were 
dissected to expose their hearts in oxygenated artificial hemolymph (AHL). Then high-speed 
digital movies of heartbeats were taken, and analyzed for DI, FS, etc.  
Immunostaining and Imaging 
To investigate mitochondrial morphology in heart, we used ATP5A1 antibody (1:200; 
Invitrogen 15H4C4), which marks the mitochondrial ATP synthase. We used Alexa Fluor 594-
conjugated phalloidin for F-actin staining (Thermo Fisher Scientific, A12381). All fluorescence-
conjugated secondary antibodies were from Jackson ImmunoResearch (Alex Fluor 488).  
For immunostaining, adult female flies were collected and dissected in AHL. Hearts were 
then incubated in relaxing buffer (AHL with 10mM EGTA) briefly to inhibit contractions. After 
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fixing in 4% paraformaldehyde for 15 min at room temperature (RT), hearts were washed in PBS 
with 0.1% Triton X-100 (Fisher Scientific, BP151-100) (PBST) and then blocked in 5% normal 
donkey serum (NDS; Jackson ImmunoResearch, 005-000-121) diluted in PBST for 1 h at RT. 
Hearts were then washed with PBST and incubated overnight at 4°C with primary antibodies 
diluted in 5% NGS. After washing with PBST, the samples were incubated for 2 h at RT with 
appropriate fluorescence-conjugated secondary antibodies. Hearts were mounted in ProLong 
Diamond antifade reagent (Thermo Fisher Scientific, P36361) before being imaged using a 
FV3000 Confocal Laser Scanning Microscope (Olympus). 
For image analysis and quantification, fluorescence images were analyzed in Olympus 
cellSens software. The mitochondria in a selected region of interest (ROI, ~400 µm2) within 
heart tube were measured with the “Measure and Count” module in Olympus cellSens software. 
To quantify the mitochondria size, the area for each object/mitochondrion was measured and 
plotted in a distribution plot.  
TMRE staining 
Flies were anesthetized and dissected in cold AHL. Hearts were then incubated in TMRE 
staining solution, consisting of 100nM of TMRE (Invitrogen, T668) in AHL for 12 min at RT. 
Samples were then rinsed twice for 30 s each wash with s solution consisting of 25 nM of TMRE 
in AHL. Hearts that attached to abdomen were quickly mounted in the same medium onto the 
slide and imaged within 15-20 min using identical setting on the confocal microscope. 
quantification of TMRE staining is done using cellSens, where mean intensity profile for the 
TMRE stains were quantified.  
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Measurement of Mitochondrial Calcium 
The Hand4.2-gal4 driver was used to drive the expression of UAS-mito-GCAMP5 and 
UAS-mito-DsRed reporter combination in adult heart. Flies were dissected to expose hearts in 
AHL, then the hearts that attached to the abdomen were immediately placed on the slides for live 
imaging. Images were taken with FV3000 Confocal Laser Scanning Microscope with a 100x oil-
immersion objective lens. The mitochondrial calcium detected by mito-GCaMP5 were 
normalized with the UAS-mito-DsRed, which represents the mitochondrial mass.  
Western Blotting for MTORC2 
The phosphorylation of AKT is used to represent MTORC2 activity (Chang et al., 2019). 
25-28 Drosophila adult hearts were collected for each sample. RIPA lysis buffer (Thermo Fisher 
Scientific, PI36978) was used to extract protein sample. Supernatants were collected and loaded 
onto Mini-PROTEAN precast gels (Bio-Rad Laboratories, 456–1095) using standard procedures. 
Blots were then incubated with primary and secondary antibodies. Primary antibodies used in 
this study included Drosophila p-Akt1 (Ser505) (1:1000) (CST, 4054) and AKT1 (Pan) (1:2000) 
(CST, 4691). All HRP-conjugated secondary antibodies are from Jackson ImmunoResearch. The 
blots were visualized with Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific, 
PI34577). The images were analyzed by Image Lab.  
Statistical Analysis 
GraphPad Prism (GraphPad Software) was used for statistical analysis. To compare the 
mean value of treatment groups versus that of control, either student t-test or one-way ANOVA 
was performed using Tukey multiple comparison. In SOHA analysis, the outliers were identified 
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using Robust regression and Outlier removal (ROUT) method (Q = 1%) prior to the data 
analysis. 
3.5 Figure and Table Legends 
Table 1. Time-dependent HFD-induced mitochondrial responses in rodent.  
Figure 1. HFD and rictor knockdown alters mitochondrial physiology in Drosophila 
heart. (A) Area of mitochondria in the heart of wildtype or cardiac-specific rictor knockdown 
upon 5 days of HFD feeding. ATP5A1 antibodies were used to detect mitochondria and 
phalloidin was used to stain F-actin. (B) The group histogram data for mitochondrial area shown 
in (A). (C) Mitochondrial membrane potential measured by TMRE in the heart of wildtype or 
cardiac-specific rictor knockdown upon 5 days of HFD feeding. (D) The intensity profile of 
TMRE measured in (C). (E) Wildtype or rictor knockdown heart expressing mito-GCaMP5, and 
mito-DsRed upon 5 days of HFD feeding. (F) mito-GCaMP5 signal is normalized with 
mitochondrial mass (mito-DsRed) to represent the mitochondrial calcium level in heart. Flies 
were cultured at 40% relative humidity. Hand-gal4 driver was used to drive gene expression 
specifically in cardiac tissues (cardiomyocytes and pericardial cells). Scale bar is 5 μm. N=4-6 
and 3 ROIs were selected for each heart sample. Student t-test (* p<0.05, *** p<0.01). 
Figure 2. HFD alters cardiac function in Drosophila. (A) Diastolic interval (DI), (B) 
fractional shortening (FS), and (D) diastolic diameter (DD) of wildtype or rictor knockdown 
heart upon 5 days of HFD feeding. Flies were cultured at 40% relative humidity. Hand-gal4 
driver was used to drive gene expression specifically in cardiac tissues (cardiomyocytes and 




Figure 3. HFD reduces rictor activity in Drosophila heart. (A) Western blot analysis on 
Akt1 phosphorylation of hearts dissected from wildtype flies treated with 5 days of HFD. (B) 
The level of Akt1 phosphorylation is normalized to total Akt1 protein. Flies were cultured at 
40% relative humidity. Hand-gal4 driver was used to drive gene expression specifically in 
cardiac tissues (cardiomyocytes and pericardial cells). N=3 and 25-27 hearts were collected for 
each sample. Student t-test. 
Figure 4. Overexpressing rictor rescues HFD-induced mitochondrial physiology 
alteration in Drosophila heart. (A) Mitochondrial size and (B) mitochondrial membrane potential 
in hearts of wildtype (Hand4.2-Gal4>WT) and cardiac-specific rictor overexpression flies upon 
5 days SD or HFD feeding. ATP5A1 antibodies were used to detect mitochondria. (C) The group 
histogram data for mitochondrial area of (A). (D) The intensity profile of TMRE measured in 
(B). Flies were cultured at 40% relative humidity. Hand-gal4 driver was used to drive gene 
expression specifically in cardiac tissues (cardiomyocytes and pericardial cells). Scale bar is 20 
μm. N=5 and 3 ROIs were selected for each heart sample. Student t-test (* p<0.05, ** p<0.01). 
Figure 5. rictor overexpression rescues HFD-induced cardiac dysfunction in Drosophila. 
(A) Diastolic interval (DI) and (B) fractional shortening (FS) of wildtype or rictor 
overexpression heart upon 5 days of HFD or SD feeding. Flies were cultured at 40% relative 
humidity. Hand-gal4 driver was used to drive gene expression specifically in cardiac tissues 
(cardiomyocytes and pericardial cells). N=21-25. Student t-test (* p<0.05, ns: not significant).  
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4.1 General Conclusions and Discussion 
This dissertation summarized the investigation of the regulation of age- and metabolic-
related cardiomyopathy in Drosophila. These studies highlighted the role of MTORC2 in the 
regulation of autophagy, mitochondrial physiology, and cardiac function. Specifically, we 
discovered a novel crosstalk between INHB/activin and MTORC2 in the regulation of autophagy 
and cardiac aging in Drosophila. We also showed that MTORC2 regulates mitochondrial 
physiology and provides cardioprotection under a nutrient overload condition induced by HFD 
feeding. However, the mechanisms of MTORC2-mediated autophagy, mitochondrial physiology, 
and cardiac function require further investigation.  
As mentioned in previous chapters, MTOR functions through two complexes, MTORC1 
and MTORC2, in distinct manners to regulates a wide range of cellular functions. In summary, 
MTORC1 senses changes in growth factors, stress, energy, oxygen, and amino acids to regulate 
cellular growth and proliferation. MTORC2, on the other hand, responds mainly to growth 
factors to regulates cell survival, metabolism, and cytoskeleton rearrangement (Laplante & 
Sabatini, 2012). However, despite their structural and functional differences, the regulation of 
these complexes is also tightly linked. The activation of one MTOR complex may trigger either 
positive or negative feedback loops, which in turn could further enhance or suppress the other 
complex (Xie & Proud, 2014). Therefore, two MTOR complexes might exert an opposite effect 
in regulating the same cellular process.  
MTORC1 is recognized as the master regulator of autophagy, which directly regulates 
various autophagic processes including the initiation, nucleation, autophagosome elongation, 
maturation, and termination (Dossou & Basu, 2019; Rabanal-Ruiz, Otten, & Korolchuk, 2017). 
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Recently, emerging studies suggest that MTORC2 may also regulate autophagy even though the 
direct regulatory role of MTORC2 in autophagy has not been previously established. 
Interestingly, several studies have shown that MTORC2, opposite to MTORC1, is involved in 
activating autophagy under certain circumstances (Gurusamy et al., 2010; Li et al., 2014). In line 
with these studies, our results showed that MTORC2 activation is required to induce 
autophagosome formation observed in daw knockdown. Moreover, overexpressing rictor alone 
is sufficient to induce autophagy in our system. Our results collectively suggested a positive role 
of MTORC2 in regulating autophagy even though the mechanisms of MTORC2-activated 
autophagy still remain unclear.  
The opposite regulation of autophagy by two MTOR complexes indicates the different 
regulation of cardiac function between MTORC1 and MTORC2. Based on previous evidence, 
MTORC1 promotes age-dependent cardiac dysfunction in Drosophila (Luong et al., 2006; 
Wessells et al., 2009). However, our results showed that overexpressing MTORC1 in the heart 
produces unique cardiac changes that are different from aging fly hearts. Instead, the heart 
exhibits increased heart rate and dilation, similar to HFD-induced cardiac dysfunctions (Birse et 
al., 2010). Conversely, our results showed that MTORC2 plays a cardioprotective role during 
aging. Specifically, MTORC2 is required for the cardioprotective effect caused by daw 
knockdown, and cardiac-specific activation of MTORC2 alone could slow cardiac aging and 
prolong lifespan in Drosophila. Consistently, previous studies have also shown that disrupting 
MTORC2 could result in detrimental effects. For instance, cardiac-specific deletion of Rictor 
induces cardiac dysfunction in mice (Sciarretta et al., 2015); deletion of Rictor decreases lifespan 
in male mice (Lamming et al., 2014); and mutation of rictor and sin1 leads to reduced tolerance 
to heat stress in Drosophila (Jevtov et al., 2015). It is noteworthy that one of these previous 
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studies suggested that the hippo pathway is involved in MTORC2-mediated cardiac function 
(Sciarretta et al., 2015). Therefore, investigating the crosstalk between the hippo pathway and 
MTORC2 in regulating autophagy and cardiac function might be a future direction.  
When we examined the activity of MTORC2 during cardiac aging, we found that the 
immunostaining of pAKT1 exhibits as puncta in fly hearts. Since MTORC2 has been found 
localized to MAMs (Betz, Stracka, Prescianotto-baschong, Frieden, & Demaurex, 2013), we 
speculate these pAKT1 puncta may be associated with mitochondria and ER subcompartment. 
Even though the direct regulation of MTORC2 in mitochondrial function is still unclear, indirect 
evidence showed that MTORC2 is involved in mitochondrial dynamics. For example, 
overexpression of rictor rescues Pink1 knockdown-induced mitochondrial aggregation in 
Drosophila indirect flight muscle (Wu et al., 2013), and MTORC2 downstream target AKT have 
shown to interact with mitochondrial dynamic proteins DRP1 and MFN2 (Kim et al., 2016; Xu 
et al., 2017). Our results further confirmed the regulatory role of MTORC2 in mitochondrial 
physiology. We found that cardiac-specific activation of MTORC2 rescued HFD-induced 
mitochondrial fragmentation, loss of membrane potential, and calcium overload. Further work is 
needed to examine how MTORC2 regulates these mitochondrial physiologies. Investigating the 
regulation of MTORC2 at MAMs could be one of the future directions.  
In summary, our studies identified a novel cardioprotective role of MTORC2 during 
aging and a nutrient overload condition. It also highlighted the role of MTORC2 at the 
intersection of signaling pathways that regulate aging and nutrient sensing. Indeed, it is generally 
accepted that nutrient-sensing pathways that regulate metabolism and growth can also promote 
aging and mortality. MTORC2 responds to growth factors and act as an effector in insulin/PI3K 
signaling. Mutations in the growth hormone-IGF1 signaling extend lifespan in various model 
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organisms and insulin resistance is one of the first cellular changes in nutrient overload 
conditions (e.g. HFD) (Altintas, Park, & Lee, 2016; Hancock et al., 2008; Junnila, List, 
Berryman, Murrey, & Kopchick, 2013; Kimura, Tissenbaum, Liu, & Ruvkun, 1997; Miotto, 
LeBlanc, & Holloway, 2018; Thomas et al., 2014). Therefore, it is likely that the growth 
hormone-IGF1 signaling is the common upstream mediator for MTORC2 signaling during both 
aging and nutrient overload conditions in the Drosophila heart. We have also identified that 
MTORC2 positively regulates autophagy and mitochondrial function in the Drosophila heart 
even though the detailed mechanisms require further investigation. Understanding the crosstalk 
between MTORC2 and other signaling pathways such as the hippo pathway, and investigating 
the regulation of MTORC2 at MAMs in the future could provide more insights into MTORC2 
downstream regulation. 
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